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Statement of Integration 
Kennesaw State University offers a Master of Science in Integrative Biology program 
designed for training research scientists to critically think across multiple disciplines. In addition, 
developing the confidence to ask and answer questions probed from all professors within the 
biomedical science discipline to acquire a deeper understanding of biological systems from small 
to large scales. For this project, we address questions regarding social and biological factors that 
influence drug use among adult populations in the United States. We also address questions 
regarding specific needs of rural North Georgia/Southern Appalachia areas and the effects of the 
opioid epidemic among these populations, particularly women opioid users living in the rural 
North Georgia area. Many hours were spent analyzing datasets and conducting one-one 
interviews with professionals, past users, and family members of past opioid users who are all 
involved in the prevention and treatment of opioid addiction. Additionally, many hours were 
spent preparing and forming appropriate recruitment processes for the North Georgia region that 
has disproportionately been effected with opioid use disorders. 
We included opioid users from the National Survey of Drug Use and Health (NSDUH) in 
this study, and location and access of the study dataset were provided from a federally 
government-funded organization, the Substance Abuse and Mental Health Services 
Administration (SAMHSA). Many study participants were recruited from using the Georgia 
Bureau of Investigation (GBI) records, Georgia Heroin Task Force, The Zone recovery facility, 
and the Department of Public Health reports (DPH). It was imperative for the success of this 
project to involve these organizations and it also served to expand the integrative scope of this 
project and program. 
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This thesis project is taking on a broad scope of integration, encompassing community, 
law/policy makers, health-care professionals, statistical analysis, and biological concepts 
working together to employee techniques from disciplines ranging from sociology, mathematics, 
and neuroscience. Completion of this project has allowed me to develop creative problem-
solving skills as a research scientist, as well as make meaningful connections between diverse 
biological concepts and social/cultural factors that influence unique substance use disorder 
behaviors at the community level. 
Chapter I: Introduction 
Abstract 
  Since the early 1800s scientists have been working to create the best non-
addictive pain medication derived from opium. In the early 1800s morphine was distilled from 
opium extracted from opium poppy plants (Quinones, 2015). Soon after a chemist invents a 
synthetic derivative of opium and names it diacetylmorphine (heroin) (Quinones, 2015, (Drugs 
and Morphine Text, 2018). Heroin originally was a safe cure for morphine addiction. Once this 
was proven to be false, and as having addictive properties, the government intervened and began 
initiatives to address the issue. This public crisis quickly grew to what modern scientists and 
healthcare professionals know now as the "Opioid Epidemic." The opioid epidemic began around 
the early 1900s when doctors power to prescribe painkillers became more frequent and in larger 
quantities, to patients who suffered from more moderate pain (Quinones, 2015). This lead 
researchers such as myself and many others to investigate the addictive determinants of this very 
popular medication. In this thesis project we hypothesis social factors, along with biological 
factors, influence opioid use among adult females living in rural areas. Because no current 
research provides evidence-based data are available on adult female substance use disorders 
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(SUD), we were inspired to collect data on this overlooked subpopulation. Using a mixed 
methods approach to address this concern, we quantified a robust and comprehensive dataset 
obtained from the national level. Also, we conducted a qualitative analysis of the rural North 
Georgia area to supplement findings from the quantitative analysis data. 
The Problem 
For this study, we used social and biological theories to elucidate the specific needs of women 
living in rural North Georgia, who have experience with SUD. The goal of this project is to help 
establish a better foundation for understanding addictive behaviors and eventually help better 
healthcare policy, scientist and public healthcare professionals and the community they serve. To 
address the concerns above, we designed the following experiments: 
Hypothesis: Social and cultural factors influence opioid use among adult females living in rural 
communities, particularly North Georgia. 
Specific Aim 1: in this study, I plan to identify the correlation of the evolutionary reward system 
in the brain with specific common drug addiction factors, which play a role in drug-seeking risky 
behaviors. 
Specific Aim 2: a quantitative analysis on a comprehensive pre-existing dataset (National 
Survey on Drug Use and Health: NSDUH), will be done to define the unique social and cultural 
characteristics of rural adult females. 
Specific Aim 3: this dataset provides limiting specificity to distinctive rural Georgia/ Southern 
Appalachian areas. Therefore, supplemental qualitative interviews and focus groups with female 
past opioid users, family members, and professionals involved with prevention and treatment of 
opioid use will be done to identify specific social factors of North Georgia/Southern Appalachian 
residents.  
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Impact: Understanding social and cultural differences between rural and urban female opioid 
users will provide specific data to enhance public awareness, as well as, provide documented 
research on this overlooked population for medical providers and healthcare policy decision 
makers. 
Chapter II: Literature Review 
Addiction as a disease 
Addiction is a condition that can be both physically and socially a concern for drug users. 
The opiate molecule is one that simultaneously relieves pain and triggers the reward pathway in 
the brain. Although opioids were designed to mask symptoms of pain, their addictive properties 
cannot be overlooked and are often not recognizable to drug users. Addiction occurs when the 
dopamine reward pathway is triggered and altered from chronic opioid use. A person can 
become dependent on opioids, which is when normal body functions can no longer function 
physiologically. Opioids relieve pain through the peripheral nerves or pain neurons. In a normal 
condition where the body is receiving a pain sensation, the pain neuron would need to change the 
voltage in the axon terminal end from negative charge to positive charge for to let out the 
neurotransmitter.   
The neurotransmitter binds to the endogenous opioid receptors (mu receptors) in the brain 
to communicate a pain signal. The only way the pain signal can be activated is for the 
neurotransmitter to be released, which requires a positive charge in the axon terminal region. The 
neurotransmitter releases from the axon terminal in the synapse, then bind with the dendrite to 
receive that pain signal. However, in the presence of chronic opioid exposure (such as Heroin), 
the opioid will bind to the mu-opioid-receptor and then communicate to a second messenger in 
the cell. This then causes the potassium channel to open on the axon terminal end and lowers the 
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voltage potential to be more negative. The increase of negative voltage potential prevents the 
neurotransmitter from being released out into the synaptic cleft. This leads to a buildup of opioid 
(Heroin) molecules in the synaptic cleft which also leads to a constant excited state where the 
dopamine neurotransmitter is always triggered. Eventually, this excited state will lead to 
addictive behaviors because the excitatory neurotransmitter dopamine is on the transmembrane 
of the dendrites ready to bind the free opioids (Heroin) in the synaptic cleft. 
The brains' reward pathway has evolved over the years to adopt the importance of self-
preservation. The reward system is responsible for determining what good or bad stimuli are. 
The excitatory neurotransmitter is responsible for the motivation and memory of a stimulus. 
However, dopamine alone does not cause the experience of pleasure but is suggested to be 
involved with translating detailed memories about reward (e.g., where to get it, how to get it) and 
contributes significantly to social and environmental stimuli that can be associated with the 
reward (Hiroi & Agatsuma, Genetic susceptibility to substance dependence, 2004). Three 
important areas in the brain attribute to addictive behaviors, which are, personality, emotional, 
and rational. In neuroscience, the definition and primary functions of the reward system are a 
collection of neural pathways and brain structures that attribute reward-related cognition, such as 
conditioned learning, incentive learning such as, craving and desire for a reward and positive 
emotions, particularly emotions related to pleasure (Hiroi & Agatsuma, Genetic susceptibility to 
substance dependence, 2004). 
When a person uses a drug repeatedly, these behaviors can become prevalent and can 
lead to ones' addiction. For addiction to occur the dopamine reward pathway must be activated, 
and for the reward/pleasure pathway to be activated, dopamine must communicate through this 
reward. The neurotransmitter dopamine releases only during a pleasurable or rewarding stimulus. 
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Therefore, in a normal state, at rest, the inhibitory neurotransmitter GABA will prevent 
dopamine from being released. In the presence of chronic opioid exposure, GABA is stuck inside 
the cell where there is a more negative charge and can't reach the outside GABA receptor to 
communicate effectively (Hiroi & Agatsuma, Genetic susceptibility to substance dependence, 
2004). The opioid buildup in the Synapse continues to bind the mu-receptors, while dopamine 
neurotransmitter bind to the dopamine receptors sitting on the dendrite transmembrane. At this 
stage, the dosage of opioid exposure is associated with a pleasurable sensation in the brain. 
Opium was studied extensively for its medicinal properties. The morphine molecule has evolved 
to fit, "key-in-lock," into the mu-opioid-receptors naturally found in the human brain and spine. 
Morphine overwhelms the receptor and creates an intense euphoria more-so than any other 
internal substance. 
The rise in opioid misuse has many underlying contributing influential factors such as 
poor healthcare, family substance abuse history, gender biases, and many others. One important 
factor about the direct effect of using opioids is, they are highly potent painkillers while 
notoriously being known for their ability to produce euphoria which can lead to addiction. 
Previous research studies were aimed to elucidate the gender differences in opioid experience 
and susceptibility; however, no clear conclusion has been identified. Although there are many 
sociocultural factors, there are also many biological factors that play a role in pain perception 
and drug abuse. These authors hypothesized that gender differences among opioid users’ 
experience are a likely result from cross-communication with opioid receptors and estrogen 
when stimulated by the exogenous opioids, through common downstream transcriptional factors 
and secondary messengers. 
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This study focused on primary literature searches, which were analyzed and identified for 
their knowledge of gender differences, opioid use disorders (OUD) and estrogen and opioid 
receptor interactions. The group analyzed reports in humans and animals with ten groups of 
opioids analyzed in humans and seven groups analyzed in animal studies. This team could 
determine which endogenous opioid receptors were affected for each type of opioid, along with 
the effect differences seen among women and men. 
 For years, men have reportedly been affected by OUD more so than women although, 
women are more likely to experience chronic pain and more severe pain at higher frequencies 
than men. Results show that Buprenorphine, among receptor ORL1 agonist, MOR partial 
agonist, KOR antagonist, affects women and men equally. Butorphanol users, among receptors 
MOR partial agonist and KOR agonist effect women and men the same. Fentanyl at the MOR 
agonist receptor affects males more than females sometimes but can have similar effects on both 
sexes. Morphine products at the MOR, KOR and DOR agonist receptor are shown to either 
affect males more than females or have a similar effect, depending on the source of pain. Heroin 
at the DOR, KOR and MOR agonist receptors have been shown to affect more adult males with 
OUD than adult females with OUD. Whereas, young adolescent females are more likely affected 
by opioids. The remaining drug groups are for supplemental purposes.  
In animals, Buprenorphine at the ORL1 agonist, MOR partial agonist, and KOR 
antagonist males are more affected than females. Butorphanol attaches to the MOR partial 
agonist and KOR agonist and can affect males and females differently depending on the source 
of pain. Fentanyl binds to the MOR agonist and more likely effects males more than females. 
Morphine in animals attaches to the MOR, DOR and KOR agonist and effects male sand females 
the same or more likely males are affected. For heroin use at the DOR, KOR and MOR agonist, 
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adult males are more affected than adult females. At the KOR agonist, more adolescent females 
are affected than adolescent males. 
 The findings from this review suggest that the direct mechanism of opioids and receptor 
interactions are considered when studying opioid addiction. It is known that animals without the 
estrogen receptors ER-alpha, ER-beta, or GPR30 lack the estrogen-regulated opioid effects. 
Opioids and estrogen receptor functional interactions should be investigated to provide better 
insight into gender differences in addiction and analgesia, at both the cellular and physiological 
levels. 
Addiction as a social issue 
 In retrospect, opioid prescriptions were used for therapeutic purposes. Initially, patients 
with pain due to cancer or major injuries were the only people prescribed prescription opioids.   
This soon changed, when prescription pain relievers became accessible to people with moderate 
pain, such as back-pain and arthritis-pain. While prescription opioid dispensing increased, 
mortality due to opioid overdose increased from 8,050 individuals in 1999 to 33,091 individuals 
in 2015 (Centers for Disease Control and Prevention, 2014) (Centers for Disease Control and 
Prevention, 2016)). By 2015, opioids were associated with 63% of all drug overdose deaths in 
the United States  (Centers for Disease Control and Prevention, 2014)). Additionally, from 2010-
2015, overdose deaths related to illicit heroin use, spiked from 3,036 to 12,989 individuals (1, 2). 
The opioid epidemic has not been easy to resolve due to the influx of pharmaceuticals and illicit 
use of pure heroin products that flood local and national communities. Pure heroin and fentanyl, 
a synthetic opioid, are two prevalent opioids that take small amounts to produce adverse effects 
such as, respiratory difficulties and heart failure (Centers for Disease Control and Prevention, 
2013) . According to the Centers for Disease Control and Prevention (CDC), southern states 
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including Georgia experienced a spike in drug reports associated with both heroin and 
prescription opioid in the year 2010 (Centers for Disease Control and Prevention, 2013). Hence, 
lending itself to a high-risk population for opioid intervention and prevention that captures real-
life characteristics of Georgia/southern state communities (Cicero, Ellis, & Surratt, 2014).  
 Recent proposals suggest, explaining this epidemic through the following: (a) supply and 
demand, (b) amalgamated heroin and fentanyl product use, and (c) extremely pure heroin forms 
(Cooper, et al., 2014). In the community, mixed heroin and fentanyl products have become more 
accessible with over 2 million people reporting opioid substance disorders. Also, 600,000 of the 
reports involved the use of heroin (Drugs and Morphine Text, 2018). The easy access, high 
purity concentration, and inexpensiveness of these drugs result in quicker rewarding effects from 
the drug use. Consequentially, this traps an addict, and prescription opioids become a gateway 
for heroin use (Frank, Susan, Ingrid, Brenner, & Levy, 2015).  
 Individuals initially hooked on prescription opioids, nearly 75% of them will eventually 
turn to heroin (U.S. Department of Health and Human Services, 2015). The potency and 
speediness of heroin and fentanyl on the brain make mixing the two far more dangerous than 
when they're used separately. Due to the high prevalence of these drugs in communities, the 
opioid epidemic has reached the drastic results we see today and will continue to rise if not 
addressed quickly (U.S. Department of Health and Human Services, 2015). The simultaneous 
effects of pain relief and reward have led to the increased use of opioids and adversely, the rise 
in deaths related to opioid use. These unwanted negative effects have swamped vulnerable 
populations and support the need for health policy reform, and thereby, more research is needed 
on this issue. 
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 Continuously, researchers work to reveal the source of opioid addiction. Recent studies 
determined that many factors including genetic, governmental, and individuals' lifestyle 
(environment and social) play a significant role in increasing one's susceptibility too opioid 
addiction (Cicero, Ellis, & Surratt, 2014). From a public health perspective, addiction is 
continually impacting human health at all levels, from the individual to the family and society. 
Although treatment is sometimes available for individuals, there is a shortage of successful 
programs designed to help the families of users and adequate prevention plans to address health 
disparities, especially in rural areas. Advancements in healthcare and policy will provide more 
effective prevention education for opioid addiction and to do so, it is important to understand the 
underlying biological and social factors.  
 According to the CDC, 2015-2016, between 1999 and 2014 prescription opioid overdose 
mortality rates were among Native Americans and non-Hispanic white males aged 25 to 54 years 
old. High prescription opioid (PO) rates (6 times higher than the national per capita rate) 
correlate with factors such as high predominately non-Hispanic white population and rural areas 
affected by a high prevalence of diabetes, arthritis, back pain, high unemployment and high 
Medicaid enrollment. The CDC, 2016 has recently reported increased mortality rates for women 
and youth (age 12-17). This led our interest to women and rural geographic locations in Georgia. 
 Based on nationally representative survey data and local state-based data, it is suggested 
that rural areas have higher mortality and injury rates, but also adolescents are more likely to use 
PO than their urban counterparts respectively. Survey data also show that social factors such as 
depression and poly-drug use are associated with PO and heroin use in rural areas (SAMHSA, 
2017). To understand the uniqueness of rural areas we should understand what makes them 
unique compared to metropolitan populations. The social dynamics that explain why these 
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residents are more susceptible to opioid misuse remains limited. A model of drug risk factors is 
grounded in ecological systems theory and Eco-social theory. The macro model suggests that 
social factors structure the availability of drugs and the norms around use such as inequality, 
economic deprivation, structural discrimination, and pervasive stressors in the environment.   
Over the past two decades, the availability of recreational drugs has shockingly increased, 
especially with the rise in novel psychoactive substances (NPS). Places such as Australasia, 
Europe, and North America have played a role in producing NPS like cannabis, stimulants and 
more recently, opioids. Synthetic NPS such as ‘opioid-MT-45' (1-Cyclohexyl-4-(1, 2-
diphenylethyl) piperazine, have become widely available through internet and media sources. 
Opioid MT-45 was discovered in Japan, to have opioid analgesics in the 1970s. However, new 
NPS often have very scant information on potential toxicity associated with it. This study aimed 
to elucidate the characteristics of MT-45 as a potential NPS, through the process of data 
triangulation (Siddiqi, Verney, Dargan, & Wood, 2015). 
First, characterizing relevant ‘opioid MT-45' associations was done by gathering 
published scientific and ‘grey' information sources to understand MT-45 as an NPS. MEDLINE 
and PubMed websites were searched using the keywords: ‘MT-45' and ‘1-Cyclohexyl-4-(1, 2-
diphenylethyl) piperazine'. Continuously, abstracts from the 2010-2014 North American 
Congress of Clinical Toxicology (NACCT) and the European Association of Poisons Centres 
and Clinical Toxicologists (EAPCCT) meetings were examined for the same keywords. Utilizing 
the search engine ‘Google' and several other online drug discussion forums, the same keywords 
were searched for the ‘grey' source. Collectively, the published information was analyzed until 
theme (theoretical) saturation was identified and extracted from the sources.  Also, a second 
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supplemental search was done on the internet to determine the cost and pricing of ‘opioid MT-
45'. 
Triangulated results showed there were very few articles and published information 
available on MT-45. A total of 20 reports were found on the discussion forums resource: the 
EMCDDA-Europol joint report on MT-45, one government report on two deaths related to MT-
45 in the US, and one scientific report on acute harm associated with MT-45 use. During the year 
of this study (2014), there were no population reports related to the prevalence of use of MT-45. 
Out of the 20 reports found during the searches, the most common route to inject MT-45 was 
oral (65%), nasal (20%), inhalation (10%), and rectal insertion (5%). The dosage average ranged 
from 60-100 mg between the 20 cases, with each mode of injection resulting in different amounts 
of use. There were 17 internet sites identified for selling MT-45 in powder form; 9 had no direct 
cost information (only account user access) and 8 had accessible cost information available on 
their site. The most common effect desired by the users was the euphoria ‘high,' the long half-life 
(up to 12 h.), and the potency of the mimicking activity (80%) of morphine. Future studies could 
further investigate if ‘opioid MT-45' is just as addictive as prescription opioids such as 
Oxycodone and Hydrocodone (Siddiqi, Verney, Dargan, & Wood, 2015).  
The methods used for this study could be applied to a fish species model, to identify 
specific behaviors seen when under the influence of an NPS such as ‘opioid MT-45'. The data 
gathered during the triangulation process can be a guide for future researchers to classify risky 
behaviors related to NPS use. Data triangulation is a good method to use when using multiple 
disciplines and areas of research to answer complex questions. 
Domestic violence is often associated with emotional, physical, verbal, sexual abuse, 
financial hardships, or child distress when children are involved. This abuse occurs between 
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current or former intimate relationships and can be prolonged even after ending the relationship 
with the abusive partner. For many years, abuse has affected both men and women; however, 
women are often disproportionately subjected to experiencing domestic violence during their 
life. In 2001, statistics showed an estimated one in four women experiences abuse from their 
partner in their lifetime. In addition, the social influencers of why women stay in domestic 
violence relationships (DVR), has not been thoroughly elucidated. This study aimed to gain local 
information on violent experiences, among women living in a rural County in North England 
(Bostock, Plumpton, & Pratt, 2009). 
The research team approached their objective by conducting a qualitative study of women 
in a mixed rural and urban area of Northern England. This qualitative method had the three 
following aims: explore individual DVR experience, understand tactics used during DVR and 
effects of abuse and, propose prevention and intervention implications for rural communities. 
The study consisted of twelve women from this rural area of northern England, who volunteered 
to participate in this study. The participants were recruited via several voluntary sector services 
agencies and were asked to share their DVR experience during an interview. The interview 
lasted for an hour, and there were no compensations for participating, other than informing the 
public of project findings'. The interviewers used a question guide to conduct the interviews, 
which was devised by the team and a local women's support group. The produced data were then 
analyzed using grounded theory, after completion of all interviews. Thereby, following other 
consistent studies, the group did not begin their interview structure pre-ordained hypotheses 
about participants' DVR experiences. Utilizing grounded theory begins with ascribing open 
codes to the interview text and, then interviews were checked, transcribed and themes were 
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identified. The researchers also consulted with additional women in a support group, to validate 
and check the meaningfulness of the theme labels (Bostock, Plumpton, & Pratt, 2009). 
  A total of twelve women participated in this qualitative study, and their information was 
collected and analyzed thoroughly at a later phase. The participants reported a range of 2-20 
years of dealing with domestic abuse, and all of them had been in touch with agencies regarding 
their DVR experiences. The interviewees aged from 21 to 56 years old, with one lesbian 
relationship and the remainder in heterosexual relationships. Two participants had young 
children, and three other participants resided in a Refugee camp during the time of the interview. 
Although all twelve women encountered services, the nature of the used services varied among 
each participant, as well as, their demographics and socioeconomic status. One limitation with 
this article is that all the demographic and socioeconomic data is not presented, and therefore no 
true representation from this population can be concluded (Bostock, Plumpton, & Pratt, 2009). 
  A good strategy that the authors used in this study were utilizing open-ended questions 
during the interviews; this was good because it generated more detailed responses from the 
participants. After analyzing the data with a grounded theory approach, four themes were 
identified: (1) how women lived with abuse; (2) the response of systems reinforced or challenged 
the abuse; (3) commonalities and contradictions in the DVR experience; (4) dealing with the 
abuse beyond the end of the relationship. The main finding of this study was, safety for women 
and children who try leaving a DVR depends on resources around the victim. These resources 
include, but are not limited to: family, friends, police, work colleagues, legal, social and health, 
and voluntary services. The problem with many these services within this area is, they're not well 
equipped to support abused victims financially or emotionally. For instance, participants often 
described leaving the abuser as a process rather than a one-time event. This correlated with 
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support systems perpetuating practices and views that normalize domestic violence, allow male 
privilege (such as not challenging the cost of women leaving home, relationship), or placing the 
responsibility of the relationship on the woman. Future research can focus on the services and 
their contribution to influence some of the issues presented here (Bostock, Plumpton, & Pratt, 
2009) (Bruneau, et al., 2018). 
In the past, researchers published literature supporting the concept of secure attachment, 
which is the psychological connection with others, regarding their ability to successfully adapt 
environmental stressors over a lifetime. Researchers believe secure attachment contributes to the 
independence and maturity adaptation in these individuals, dealing with social and problematic 
challenges. For many years, scientist h conceptualized insecure attachment as a predictive cue 
for addictive behaviors in adolescents and linked insecure attachment to problematic drug and 
alcohol abuse among adults. Although there is growing research on how insecure attachment is a 
risk factor for developing drug or alcohol addiction, there is very little knowledge of how 
insecure attachment provides resilience against drug or alcohol conditions. In this study, the 
group aimed to investigate the correlation between attachment security and at-risk drug or 
alcohol abuse (Bruneau, et al., 2018).  
To address the relationship between attachment security and problematic drug or alcohol 
use, the researchers examined a sample of suicidal, depressed women with several risk factors 
for problematic drug and alcohol abuse. Using a collaborative collection of baseline pre-
intervention assessments data and the African American Women (AAW) sample, the researchers 
formed a participation group for this study. The AAW were 18-64 years old and reported having 
homicidal, suicidal, or acute psychotic symptoms in their lifetime or past year (Cooper H. L., et 
al., 49). The Grady Nia Project, which is aim is to reduce suicidal behavior among AAW, was 
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the organization responsible for developing the assessments used in their projects. Demographic 
data was survived through a Grady Nia Project questionnaire. Two tests were used for the drug 
or alcohol assessment: (1) the Brief Michigan Alcoholism Screening Test (b-MAST); (2) the 10-
item Drug Abuse Screening Test (DAST-10), which were defined as problematic for drug or 
alcohol abuse if they scored a six or higher on each test respectively. Relationship Scales 
Questionnaire (RSQ) is a widely-used adulthood attachment test, and they were used in this 
study for the attachment security test. In addition, a childhood maltreatment test was given, using 
the Childhood Trauma Questionnaire-Short Form (CTQ-SF). Finally, statistical regression 
analyses were conducted using the participant data (Cooper H. L., et al., 49) (Cooper H. L., et al., 
2014).  
On average, participants were 35.1 years of age, with the youngest being 19 and the 
oldest 61 years old. About 40% had less than a high school education; 86.2% were unemployed; 
37% reported a psychiatric hospitalization, and 54% said they were homeless. Over half of the 
sample (56%) endorsed problematic use of drug or alcohol, 53% endorsed both, 40% endorsed 
drugs only, and 7% endorsed alcohol only. Older women had lower attachment security, 
homeless, and had greater severity of childhood trauma, typically suffered from problematic drug 
or alcohol use compared to women who did not report substance use. Domestic violence, 
depressive symptoms, employment status, and educational attainment, did not differ significantly 
between problematic women and women who do not use substances. 
Despite hypothesizing attachment security would be linked to non-problematic drug or 
alcohol abuse, the researchers found important results. The group found an independent, inverse 
relationship between attachment security and problematic substance abuse. Surprisingly, AAW 
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who reported feeling close to family and friends, were about half as likely to report problematic 
alcohol or drug use, even when accounting for problematic use of drugs alone.   
  Incarceration over the past several decades has increased tremendously, especially the 
incarceration among African American males. Since the 1980s, the number of people in jail or 
prison increased 449%. This huge increase is due to the war on drugs in the US. Drug possession 
charges account for over 60% of the arrest made in 2008. Black men are disproportionately 
affected every year, by this trend. Whites were 2.8-5.5 times less likely than blacks to have lower 
rates of drug-related arrest, in this population-based observation. A growing body of research 
literature, related to incarceration is emerging and becoming a more powerful social force. 
However, there is little research on what happens to women who lose their partner to a jail or 
prison sentence. Therefore, the purpose of this study is to analyze the processes through which 
partner incarcerations is related to patterns of substance misuse among AAW over time (Cooper 
H. L., et al., 2014).  
  To explore this topic, the group conducted a longitudinal qualitative study on women 
over the course of 11-months. This allowed the team to investigate how losing a partner to jail or 
prison influenced their substance abuse disorders. Females were eligible for the study if they; (1) 
live in the Atlanta metropolitan area; (2) be an AAW 18-64 years old; (3) have a primary partner 
who had entered prison or jail in the past 12-months. This group used mixed strategies to recruit 
women for this study, such as posting flyers about the study and harm reduction programs. 
Interviews were conducted in a private space and lasted about 90 to 120 minutes, and the 
participants were given $25 to compensate for their efforts in the study.   
 A total of 17 women were interviewed for this study characterizing the experience of loss 
of partners in the criminal justice system. The average age for the AAW was 32.2 years old, and 
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women on average lived with one or no children. Women reported being with their partner for 
four or more years before he was incarcerated. Almost 60% of the sample had some college 
education or a college degree. Shockingly, their average income during the year of their partner's 
arrest was $15,000 to $19,999. Women reported low income despite having an education 
because they were limited to job options due to their substance abuse problems. One limitation 
the authors faced in this study is the low volume of participants, which may not be accurately 
representative of this population. 
 Mass incarceration of Black men has often been understood as a potent manifestation of 
structural discrimination. Over the years, mass incarceration has become more and more 
powerful as a social force. This study aimed to elucidate the influence of losing a partner to jail 
or prison, on AAW drug use issues. A large percent of the women reported “hitting rock bottom” 
or at their lowest point financially and emotionally after a partner has been incarcerated (Cooper 
H. L., et al., 2014) (Cooper H. L., et al., 49).  
Rural and Urban differences and OUD studies 
Between 2010 and 2011, national data reported that 425,000 individuals aged 12 and 
older were injecting drug users in the United States. Injection drug use is a risk factor for 
increased overdose, drug dependence and blood-borne infections, which disproportionately 
affect injection drug users (IDUs) within their first years of injecting. Some factors associated 
with transitioning from non-injection to injection drug use are homelessness, unemployment, 
exposure to violence, insecure income, childhood abuse, transactional sex, low education, and 
early-onset substance use and abuse. The purpose of this study was to determine the rate of 
transition from non-injection to injection drug use, evaluate the independent association of 
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specific drugs with lifetime non-injection and injection use and to determine substances most 
frequently in IDUs initiation to injection, in a rural Appalachian Kentucky population. 
The participants were 18 years old and older, resided in Appalachian Kentucky, used 
heroin, prescription opioids (PO), crack/cocaine or methamphetamine within the past 30 days. A 
questionnaire was administered by a team interviewer to determine self-reported behaviors. The 
overall sample size was 503 with 394 being IDUs and 109 were non-IDUs. After the completion 
of an interview, the respondent was compensated with $50 for participating in the study. The 
interviewers queried about the type of substance use, age of first use and first injection, arrest 
history, and the conclusions were generated. 
On average, the respondent’s age was 32.5 years old, with a range of 18-65 years old. 
Participants were predominately non-Hispanic white (94%) and were 57% male and 43% female. 
About 57% had completed high school, and many had arrest history (65%), and 60% were 
arrested before injection initiation. History of trauma, age, gender, race, education, 
homelessness, and employment status did not differ between IDUs and non-IDUs. However, 
IDUs had significantly higher incomes and were more likely to report criminal history and arrest 
and sexual activity with other IDUs. Of the IDUs, 48% used OxyContin for their first injection, 
30% used stimulants, and 14% used another PO (Staton M. , et al., 2018). Most of the 
respondents said they started injecting initially after the year 1995, which is when OxyContin 
was approved for the market. Independent associations were observed between IDU and lifetime 
use with heroin, OxyContin, stimulants and illicit methadone. Participants who had ever used 
OxyContin and stimulants were more than 6.5 times more likely to inject drugs. The median time 
from which IDUs transitioned from the first illicit drug use to the first injection was ten years. 
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In this rural Appalachia sample, 78% had a history of IDU, and it is extremely important 
to note that OxyContin was most frequently involved in the initiation of injection. For 
participants initiating injection with OxyContin, the median time from which they began 
OxyContin use to their first injection of OxyContin was only three years. In many studies, 
OxyContin has been reported to be easy to break down and filter to inject, which may explain the 
rise in injection use since 1995 (Staton M. , et al., 2018). A total of eight specific drugs were 
associated with increased risk for transitioning to IDU. Some limitations in this study are: the 
location is very specific and cannot be made general across all rural locations, the variables were 
very specific and do not capture all vulnerable risk factors associated with drug use and abuse. 
For many years, injection drug use was associated with the transmission of Hepatitis C 
(HCV) and HIV and posed a significant public health concern among the United States 
(Strickland J. C., 2017) (Strickland J. C., 2017) (Staton M. , et al., 2018). However, little 
research has focused on the correlation of injection drug use (IDU) among rural opioid users, and 
other subgroups, practically women. In the Appalachia area, in rural areas specifically, the 
prevalence of IDU among drug users estimated as high as 75%-78%. Therefore, this study aims 
to understand better the health correlations of IDU among rural women living in the Appalachia 
area, by examining (1) differences between non-injectors and injectors and (2) the unique 
correlates of recent IDU and past IDU. 
The recruitment phase of this study included 900 women from 3 rural jail facilities in 
Appalachian. Each woman was randomly selected for their interview session, which was held in 
a private group room within the prison facility. The screening assessments were administered in 
a group setting with exceptions for participants with limited reading ability. The interviews 
lasted about 20 minutes and the instruments used are: NIDA modified Alcohol Smoking 
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Substance Involved Screening Test (NM-ASSIST) and demographics. Injection drug use status 
was based on self-reported data.  
The average age of this group of women is 32 years old, and 99% are white. Of the 
participants, about 68.3% reported having at least a high school education or GED. Women in 
this study self-reported IDU, which 75.3% of the participants reported IDU in their lifetime. In 
addition, 60% of this group reported IDU within the year before their incarceration. Results show 
new injectors were younger compared to non-injectors however, no differences were observed 
between past injectors and non-injectors. Results also show, having an injecting partner, more 
male sexual partners, and drug use severity are strongly correlated with injection practices 
(Terplan, Longinaker, & Appel, 2015) (Strickland J. C., 2017) (Strickland J. C., 2017). 
HCV infections and a steady increase in opioid injection are strong correlations to IDU 
and are higher in the Appalachian women drug using population. Findings from this study have 
consisted of previous studies that demonstrated a link between HCV and IDU. New injectors and 
past injectors both reported riskier sexual behaviors compared to non-injectors. This study and 
others should be used as a guide for future research to focus on relationship context reducing 
high-risk injection practices (Strickland J. C., 2017) (Lander, et al., 2010). 
Treatment Episode Data Set, the National Survey on Drug Use and Health (NSDUH), the 
National Institute on Drug Abuse (NIDA) and Drug Abuse Warning Network (DAWN) have all 
reported an increase in prescription medication over the last decade. In rural Virginia alone, 
overdose related to drugs increased by 300% between 1997 and 2003. During the last decade 
alarming increases in an overdose which involved prescription medications, identified by 
toxicology. However, little is known about this group of decedents other than prescription 
poisoning identified by toxicology and their age at the time of death. A more detailed description 
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of this group is needed to elucidate influencing factors to this substance use issue fully. 
Therefore, this group examines and reports on the manner and assigned toxicological cause of 
death (COD), notably antidepressants, benzodiazepines and prescription opioids (PO) and their 
demographics. 
Utilizing drug overdose case records from the Office of the Chief Medical Examiner 
(OCME) in rural western Virginia, the group studied cases classified as poisoning deaths 
occurring between 1997 and 2003. The group reviewed a total of 889 cases, excluding four due 
to poisoning in young children, with the youngest case being 14 years of age. Information such 
as race, gender, employment status and date of birth were extracted from the death certificates. In 
addition, the toxicology reports were examined for enumeration. The analyses were in the form 
of cross-tabulations, where chi-square tests were performed for statistical significance. 
In 1997 overdose related to drugs consisted of 69 reports and in 2003 a total of 220 cases 
of overdose were reported, specifically in rural western Virginia. Overall, cases with a COD 
involving poly-drug use resulted in 58% of the cases. Opioids impacted 74% of the cases; with 
heroin present in 2.4%, hydrocodone present in 20.4%, methadone in 28% and oxycodone in 
19.6% of the cases. Antidepressants were found in 49% of all the cases and Benzodiazepines 
present in 39.3% of the cases. Because the population in this area is predominately white, the 
cases were 96.8% white and 63% were males (Wunsch, Nakamoto, Behonick, & Massello, 2009) 
(U.S. Department of Health and Human Services, 2015) (Surrat, Staton, Leukefeld, Oser, & 
Webster, 2018). The female decedents reviewed were mainly older women with the average age 
being 43 years old. Also, the greatest number of deaths occurred among adults aged 36-45 years 
old. For most cases, the decedents had at least a high school education and were employed either 
part-time or full-time. Another important note is that men were more likely unemployed or 
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disabled. The most common manner of death was by accident; male (78.9%) death was classified 
more an accident than female (57.8%); female (38.3%) deaths were classified more as suicide 
than male (18.1%) death. In addition, this group found PO were more likely to be used in rural 
areas than in metropolitan areas. 
Despite younger individuals reporting PO misuse in the NSDUH, this data shows that 
older adults aged 35-45 years are mainly affected by the opioid epidemic, specifically in this 
area. PO medications and death rates are highest in rural areas, regarding this examined 
population. Poly-drug use was predominately associated with the reviewed cases. Some 
limitations with this study are: they are only looking at one specific area and these findings may 
not be generalizable; the group should consider how rural is defined throughout the entire state, 
not just western to determine if there are geographic differences on rural communities all over, 
there is no way to determine the quantity of drug used prior to the overdose; poly-drug use is 
hard to differentiate when identifying the main COD.  
Pregnancy and opioid use disorders (OUD) studies 
For many years, social scientists have suggested differences, barriers, and challenges 
between rural and urban residents, regarding their lifestyle, health, and access to essential 
resources. This evidence lies in the fact that, in rural areas, particularly in the Southern USA, 
women have higher rates of morbidity and mortality due to cervical cancer than women in urban 
locations. Primarily, black women are disproportionately affected and are more likely to die from 
cervical cancer than white women. Moreover, the main cause of cervical cancer is the human 
papillomavirus (HPV), which recent vaccine interventions have been implemented among young 
females age 9-26 years of age. Surprisingly, no systematic approach has been taken to 
thoroughly examine racial differences in vaccine acceptability in a rural place (Wunsch, 
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Nakamoto, Behonick, & Massello, 2009) (Terplan, Longinaker, & Appel, 2015) (Lander, et al., 
2010). The objective of this study is, to examine whether rural black and white women have 
different attitudes and knowledge about HPV, HPV vaccine, and cervical cancer, to inform 
future vaccine interventions of this high-risk population. 
  Under a North Carolina at Chapel Hill institutional review board (IRB), adult women 
were recruited and given a self-administered questionnaire to complete for this study. Three 
aspects were measured and analyzed during the participant protocol. First, general HPV 
awareness was assessed through the “understanding of the natural history of HPV infection” 
prompt. The second prompt addressed the effectiveness of HPV vaccinations and if they are 
perceived as being able to prevent cervical cancer. Lastly, the third prompt focused on the 
severity and likelihood of cervical cancer. Once the questionnaires were completed, the 
participants were compensated with twenty dollars. Linear and logistic regression models were 
used to analyze the racial differences among the project participants. The analyses were 
completed unadjusted and then repeated controlling for socioeconomic status, age, and 
recruitment site.  
  Participant yield for this study was 138 women, 91 black (66%) and 47 (34%) were 
white. The following data were produced from the general demographic, infection, vaccination, 
and cancer-related question results. The women aged 18-84 years old and the average age was 42 
years old. Black women were recruited more in the public clinic than white women who 
participated in the study (86% vs. 70%, P <.05). In addition, black women reported a higher 
socioeconomic status than white women (31% vs. 11%, P <.05) who participated in this study. 
Compared to white women at 57%, only 24% of black women reported ever hearing about HPV. 
For the HPV general knowledge scale, black women scored lower than whites (29% correct vs. 
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42% correct, respectively). Regardless of race, about 20% of the respondents had heard of HPV 
vaccines before (Wunsch, Nakamoto, Behonick, & Massello, 2009). Blacks were less likely to 
agree that vaccines, in general, are beneficial and agreed that they are unnecessary, more than 
whites. Unfortunately, blacks were less likely to believe they were at risk of getting cervical 
cancer than whites (59% vs. 79%, P <.05). Future research could investigate the cultural and 
religious beliefs of the same population and determine how that effects the differences observed 
in this study. 
 There are several reasons why black and white women differ regarding their knowledge 
and understanding of health issues, such as HPV. With little research on the rural Southern 
United States, this project highlights some of the areas to focus on future healthcare interventions 
for this vulnerable population. Misperceptions and miscommunication about diseases can be a 
barrier against vaccine uptake, especially among the black rural community. These health 
educational needs among black rural women provide evidence that there is a need to develop 
better information on HPV, to make women and women who are a parent more aware of their 
high-risk and susceptibility (Staton M. , et al., 2018).  
Historically, the delivery of healthcare in rural areas has been difficult due to numerous 
social and environmental factors. West Virginia is one of the many states with ongoing 
challenges such as lack of health professionals and health care access in rural areas. From 1994 
to 2004 rates of opioid dependence have been higher among rural locations. The objective of this 
study is to inform the public of the prevalence of substance abuse among pregnant women in the 
West Virginia area.  
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The group performed a review of the literature to generate common themes or issues 
present in each study or article. The observed data were used to generalize about this specific 
population, to inform the public about this alarming issue.  
A relevant major issue among this population is Neonatal Abstinence Syndrome (NAS) 
which is affecting more and more newborns annually. This mother and fetus opioid-dependent 
challenge is often associated with fear of child protective services, addiction stigma, and legal 
implications. NAS cost an estimated $720 million dollars a year to manage the care of mothers 
and newborns suffering from opioid dependence. According to data in the National Survey of 
Drug Use and Health (NSDUH), substance abuse among pregnant women is between 3% and 
15%, depending on the age group. The group also highlights opioid use during pregnancy is 
associated with a high incidence of placental insufficiency premature rupture of membrane, 
preeclampsia and other conditions. Although there are treatments available for opioid 
dependence, administration during pregnancy should be fully examined before, during and after 
gestation. 
In West Virginia, there is a lack of drug treatment programs available for women, with 
approximately nine programs within WV that specifically target pregnant addicted vulnerable 
populations. Four major factors play a role in the shortage of treatment for pregnant opioid-
addicted women. First, physician practitioners are more likely to be dissuaded from treating 
pregnant women and neonates with substance abuse issues. Second, addicted is that women are 
more likely to have complications during pregnancy. Third, this vulnerable group is at higher 
risk for contracting Hepatitis C and HIV. Finally, in addition, mental health issues and drug use 
while pregnant, doctors tend to fear legal liability for these women and their newborns. Some 
limitations with this study are: they are only analyzing the literature for these common themes 
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and not surveying people. On the other hand, their findings are important because they are using 
them to create a better integrative approach to address NAS and substance abuse among pregnant 
women. 
In the United States, prescription opioid (PO) abuse has reached epidemic proportions. 
The rates of substance abuse admissions and deaths attributable to the PO over the past two 
decades have markedly increased. In addition, POs are identified as a precursor for heroin use. 
Without a defined optimal amount of PO after cesarean delivery, physicians struggle with over-
prescribing for their patients. This caveat has led to increased abuse of PO due to lingering 
leftover medications after they are no longer useful to the patient. This study aims to determine, 
after cesarean delivery, what amount of opioid analgesics are prescribed and consumed once 
discharged from a hospital setting. 
To investigate this concern among women a survey was generated and administered to 
women from across the US. A total of six hospitals were utilized in this study: Wake Forest 
Health Science Center (Winston-Salem, NC), the University of Brigham Michigan (Ann Arbor, 
MI), Massachusetts General Hospital (Boston, MA), Columbia University Medical Center (New 
York, NY) and Stanford University Medical Center (Palo Alto, CA). After two weeks of 
delivering via cesarean and discharge from the hospital, women were contacted via phone calls 
to do the interview. The structured interviews entailed questions regarding medication side-
effects, the opioids used and their analgesics at the time of the interview, and their overall 
satisfaction of their PO. In addition, information on patient demographics was collected. 
The recruitment process resulted in 1,065 women participants for this study, with a final 
sample size of 720 women. Results showed that 82% of the filled prescriptions were for 
Oxycodone. The proportion of women who reported pain relief satisfactory was similar across all 
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cases. The actual pain scores after delivery were also high and similar. About 15% of the women 
said the quantity they were prescribed was too low and about 36% said it was too much. Women 
who were prescribed higher quantities reported the highest prevalence of experienced opioid-
related side-effects (71%). Women with smaller quantities of medication were the least likely to 
report experiences of side-effects. Reports also show that the larger number of tablets dispensed 
correlates with a larger amount consumed and often a large amount of leftover. 
From the analysis dine in this study, the research team concluded the amount of PO did 
correlate with the amount consumed. With little to no information available on opioid use after 
cesarean delivery, physicians battle with prescribing appropriate amounts upon discharge 
patients. The excess amounts of PO may predispose people to a higher risk of consumptions 
without improvement in pain control. 
Methadone and buprenorphine are treatments used in opioid maintenance treatment 
(OMT) programs and can serve both for opioid-dependent patients in general and for those who 
are pregnant and opioid-dependent. Neonatal abstinence syndrome (NAS), methadone and 
buprenorphine exposure are associated with 40%-90% of newborns. Characteristics of NAS 
result in hyperirritability of the gastrointestinal, the central nervous system, respiratory and 
autonomic nervous system. Many research studies have investigated the effects of breastfeeding 
on NAS since breastfeeding is the optimal source on nutrition for the mother-fetus interactions. 
The study aims to determine the rate and duration of breastfeeding through a national cohort of 
Norwegian women receiving OMT. Then they compared the characteristics of breastfeeding to 
those who did not breastfeed. They hypothesized that females in OMT experience lower rates 
and shorter duration of breastfeeding than other Norwegian women and that buprenorphine-
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exposed and methadone-exposed newborns being breastfed require shorter pharmacological 
treatment for NAS than non-breastfed newborns with similar conditions. 
Utilizing Norwegian medical birth record and addiction reports, the authors performed a 
retrospective study from 1999 to 2009. The study included 136 women who gave birth to a total 
of 161 children over that decade time frame. After finalizing the data based on the desired 
criteria, a total of 124 mothers and children were included in the final analyses in this study. A 
questionnaire was created to address issues around pregnant women, NAS, opioid-dependence 
and treatment options methadone and buprenorphine. The authors went through the database of 
medical-birth records and manually filled in the questionnaire data. 
Results showed that 12% of women breastfeeding had used opiates or other substances 
during gestation and 21% of women not breastfeeding used opiates or other substances. About 
74% of the breastfeeding women were in methadone treatment (MMT) during pregnancy, and 
78% were in buprenorphine treatment (BMT) and initiated breastfeeding after delivery. The rates 
of breastfeeding at 4, 8, 12, 26 and 52 weeks of infant age were 58/56%, 53/39%, 46/34%, 
21/15% and 7/5% for women in MMT and BMT, respectively. The median length of 
breastfeeding was 12 weeks for women in MMT and seven weeks for women in BMT. The 
methadone-exposed (MMT) newborns being breastfed had a significantly lower incidence of 
NAS (53%) than methadone-exposed newborns not being breastfed (80%). 
Overall these findings suggest that breastfeeding may serve as a great resource to 
diminish NAS among at-risk mother patients. Some limitations are they did not report any racial 
or educational data to support their participant demographics; they also did not consider all 
children in the household in their study, only the first child delivered was analyzed in this study. 
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Further investigation of breastfeeding pros and cons regarding NAS, will give insight to future 
prevention and intervention approaches. 
Incarceration and OUD studies 
In the United States, opioids have grown to be one of the most popular drugs of choice. 
According to a government agency in the US (SAMHSA), and opioid use disorder (OUD) is 
defined as an inability to limit or control use, physical dependence, tolerance, and continued use 
in the presence of negative consequences. In addition, OUD has impacted pregnant women for 
the over the last two decades. Between 1999 and 2014, maternal opioid use has quadrupled from 
1.5 per 1000 delivery hospitalizations to 6.5 during pregnancy. This study aimed to identify and 
recommend strategies to optimize the care of pregnant incarcerated women with OUD, 
emphasizing the importance of appropriate counseling and treatment with opioid agonist 
pharmacotherapy. 
To address what practices are best to use on pregnant women who are incarcerated, the 
research team performed a thorough search of the primary literature. Once theoretical saturation 
was reached from their search, the team described the most commonly used practices among this 
specific subpopulation.  
The researchers found that the following data best-supported treatment during pregnancy: 
Buprenorphine, methadone, and naltrexone are the three MAT medications approved by the U.S. 
Food and Drug Administration (FDA). Both buprenorphine and methadone have been studied for 
their safety and effectiveness in pregnant populations, whereas naltrexone is not recommended in 
pregnancy. Methadone has been used in treatment for 40 years and is an opioid receptor agonist, 
lessening symptoms of withdrawal and reducing effects of other opioids such as heroin, 
morphine, or oxycodone. Its effectiveness is supported by meta-analyses of randomized trials. 
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However, buprenorphine for OUD treatment is a partial opioid agonist, meaning that it binds to 
opioid receptors producing a weaker effect than full agonists like methadone. It also has a 
"ceiling effect," meaning that the opioid effects increase with dosage to a certain threshold at 
which a larger dose does not produce a larger response, reducing the potential for misuse and 
death from overdose. On the other hand, naltrexone is not recommended during pregnancy due to 
the need to withdraw from all opioids before initiation, causing potential morbidity and mortality 
risks for the woman and their fetus if she drops out of naltrexone treatment. 
Treatment of OUD in pregnant incarcerated women is an increasingly important health 
concern for correctional facilities. The evidence-based treatment of OUD in pregnant women is 
either methadone or buprenorphine and associated mental health services such as cognitive 
behavioral therapy and group sessions. Despite these options and proven benefits, many jails and 
prisons do not offer methadone or buprenorphine to newly incarcerated women with OUD or 
patients enrolled in methadone maintenance programs, leading to acute opioid withdrawal. The 
consequences of withdrawal are especially grave in pregnant women. Providing programs for 
incarcerated pregnant patients will serve the community standard of care, improve the health of a 
vulnerable population of pregnant women, and work toward optimal health outcomes for both 
women and their newborns.  
 Opioid use is common among correctional populations, yet few inmates receive treatment 
during incarceration or post-release, particularly in rural areas. This article examines associations 
of buprenorphine use, licit and illicit, health services use, and risk for re-arrest within three 
months of jail release among rural opioid-involved women. The aim of this study is to determine 
the relationship between buprenorphine use and reoccurring arrest among women in highly 
vulnerable social and health conditions.   
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Women were randomly selected from three rural Appalachian jails. Those with moderate 
to severe opioid-involvement on the NM-ASSIST and data on patterns of buprenorphine use 
(n = 188) are in this analysis. Logistic regression analyses examined predictors of reoccurring 
arrest within three months of release from incarceration. 
The results showed there was an average age of 32-years of among the women used in 
this study. Unfortunately, only white women participated in the study, which is a limitation the 
authors plan to resolve. At the time of the follow-up, 22.7% (n=39) of these women had been 
arrested again; 5.2% (n=9) reported receiving medical assistant treatment (MAT), which all 
consisted of the buprenorphine treatment. Significant risk factors for re-arrest included: injection 
use, number of illicit buprenorphine days, number of days high and withdrawal symptoms in the 
follow-up period. It is important to note that the only form of a protective factor, was having a 
regular source of healthcare at the time of the follow-up. 
Rural opioid-involved women released from jail are highly vulnerable to re-arrest and 
lack access to supportive care systems for substance treatment. Innovations in integrating MAT 
into reentry to improve access is recommended. The authors could look further into the post 
lifestyle of these women and generate a method to track their lifestyle for 6-months, after release, 
to determine more specifically what may be the causes of this "re-arrest" observation. The 
authors should also consider analyzing the same group within an urban setting. 
Many time when people suffer from substance use disorders, they are placed in jail 
because of misconduct. However, incarceration may help resolve criminal issues and bad 
behavior among people, it does not always help with the drug use issues attached to that 
individual. Often law enforcement and healthcare officials struggle with satisfactory solutions to 
this problem because not all women are the same and do not experience jail or drug use the 
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same. This study aims to examine the criminal justice factors associated with hepatitis C virus 
(HCV) antibody reactivity and drug use, among women in rural areas across the United States. 
The participants in this study were randomly selected from the three jails used in this 
research analysis. A total of 277 women were included in this analysis, demonstrated history of 
injection drug use and came from three rural jails in Kentucky. Each participant completed a 
health and drug use questionnaire and received antibody testing for HCV after the survey was 
complete. They were given incentives to accommodate for their participation. 
Most of the women tested reactive to the HCV antibody (69%). Reactivity was associated 
with risk factors such as early age of the first arrest, criminal history, unsterile needle use, 
stigma, including an increased likelihood of prison incarceration, and a longer incarceration 
history was associated with HCV reactive tests. Participants also endorsed several barriers to 
seeking healthcare before entering jail that were more prevalent in women testing HCV reactive 
regardless of HCV status awareness before entering jail. 
Injection and high-risk sharing practices, as well as criminal justice factors, were 
significantly associated with HCV reactivity. Future research and practice could focus on 
opportunities for linkages to HCV treatment during incarceration as well as during community 
re-entry to help overcome real or perceived treatment barriers. The current study highlights the 
importance of the criminal justice system as a non-traditional, real-world setting to examine drug 
use and related health consequences such as HCV by describing the association of high-risk drug 
use and criminal justice consequences with HCV among rural women recruited from local jails. 
Managing OUD studies 
Historically, prescription opioids (PO) were prescribed to people with moderate pain 
caused by war injuries or from cancer. With the increase in opioid prescriptions, mortality rates 
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associated with opioid overdose have shockingly increased. Therefore, substantial controversy 
has risen in emergency departments (ED) across the US, due to guidelines designed to optimize 
written opioid prescription rates. Information and knowledge about physician perceptions 
regarding PO guidelines and how they apply these guidelines are scant. In this study, researchers 
elucidate important themes among ED physicians attitude toward awareness, the definition, use, 
and opinion, regarding PO guidelines. 
To evaluate physicians' opinions related to PO, a series of semi-structured qualitative 
interviews were conducted in this study. Using the American College of Emergency Physicians 
Scientific Assembly (October 2012, Denver, CO), the researchers recruited and interviewed 61 
doctors. To keep away from any basis in the study, participants varied in socioeconomic status, 
experience, and geographic region. Once all interviews were completed, the research team 
analyzed the interview data with modified grounded theory. This allowed the team to develop a 
theory from the data, which offers an explanation to a more complex question. 
Based on the interview results, doctors aware of PO guidelines defined them as state and 
national level policies that have been altered and implemented uniquely by each individual 
hospital. Physicians also said guidelines primarily are used to communicate decisions made on 
the limit of prescriptions written to patients on discharge, rather than utilized for decision 
making. Regarding the general attitudes toward PO, physicians' opinions varied. Future research 
could analyze how physicians play a role in gaining the trust of PO and heroin addicts, to help 
with their treatment and recovery process. The findings from this study suggest that PO 
guidelines within the hospital setting, often supersede national and state level guidelines. In 
addition, physicians tend to apply these guidelines primarily as a tool to communicate. 
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Understanding physicians' perspective on the PO can provide health and law policies, with 
research-based evidence on ways to address the opioid epidemic. 
In the Canadian healthcare system, opioid use disorder (OUD) is the most challenging 
form of addiction for the past two decades. Synthetic opioids such as fentanyl, carfentenil and 
prescription opioids (PO) such as oxycodone are increasingly dominating the opioid epidemic 
across the world. With an increase in drug treatment program admissions and overdose deaths, 
there is a critical need to enhance prevention and harm reduction to address this issue locally and 
nationwide. Therefore, the objective of this study is to generate a specific guideline document for 
healthcare professionals to use in Canada, as they face the opioid use disorder (OUD) continuum. 
The research team used a structured literature search approach to develop this national 
guideline. The Canadian Research Institute in Substance Misuse (CRISM) network is composed 
of four regional networks (Ontario, Quebec-Atlantic, British Columbia and Prairies), which 
developed these guidelines. Utilizing a hierarchical approach, relevant search terms and 
structured search strategies were searched in Cochrane library databases, Web of science and 
PubMed. First meta-analyses and systematic reviews were given the most weight. Secondly, 
observational studies, quasi-experimental studies, individual randomized controlled trials (RCTs) 
were weighted. Lastly, personal and expert opioid of the literature were weighted. The review 
committee consisted of 43 individuals ranging from physicians to community program managers.  
Therapeutic medications sun as buprenorphine-naloxone and methadone are considered 
as "first-and-second-line treatment options. These reversal medications are primarily the first line 
of defense for overdose symptoms. These recommendations have a moderate to the high rating 
for quality and a strong rating for the strength of the recommendation. Support and treatment 
interventions from a psychosocial point of view, should routinely be offered in conjunction with 
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pharmacological treatments. Another alternative approach is the physician specialists led 
approach. This involves a "slow-release oral morphine treatment" that is administered directly 
from the prescribing doctor. The adjunct or alternative options have a moderate quality of 
evidence but, strong strength of recommendation-SOR (with one exception and weak SOR). 
Although this study is specific to Canada, the opioid epidemic is continuing to affect people 
across the world, especially the US. This study provides good guidelines and recommendations 
for managing/ treatment of opioid use disorders. Additional research is needed to investigate the 
ideal length of treatment further. 
The role of the women in the world has changed slightly and has allowed for more 
freedom among women, than what was previously the "norm." Women are still seen as the 
caregiver and the person to care for the home in their role in society, especially here in the 
United States. Before the 1990s women who used drugs were often prostitutes or had a chronic 
medical or mental health condition. Women who use drugs today are mothers, a wife, and a full-
time employee or student. This ideal role of what a woman should be and look-like caused 
increased stigmatization and negativity among female drug users. Therefore, the author's purpose 
of this study was to examine the available options and need for women-centered substance use 
disorder treatment in the United States between 2002 and 2009. The authors obtained 
characteristics of facilities from the National Survey of Substance Abuse Treatment Services and 
treatment need data from the National Survey on Drug Use and Health. They also examined 
differences in the provision of women-centered programs by urbanization level in data from the 
National Center for Health Statistics 2006 Rural-Urban County Continuum. 
The main results from this study are; of the 13 000 facilities surveyed annually, the 
proportion offering women-centered services declined from 43% in 2002 to 40% in 2009 
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(P < .001). Urban location, state population size, and Medicaid payment predicted provision of 
such services as trauma-related and domestic violence counseling, child care, and housing 
assistance (all, P < .001). Prevalence of women with unmet need ranged from 81% to 95% across 
states. 
Change in the availability of women-centered drug treatment services was minimal from 
2002 to 2009, even though the need for treatment was high in all states. Opioid use has nearly 
quadrupled among individuals in the US and particularly has been steadily increasing among 
women. Women are expected to meet these high standards and maintain this reputation when 
they are suffering from SUD, which can often lead to more substance use. The paper utilized a 
great source to capture all the US and not just a secluded area. The NSDUH survey is the most 
robust and comprehensive national dataset available with drug-use information. 
Chapter III: Instrument (NSDUH) 
 The Substance Abuse and Mental Health Services Administration (SAMHSA), provides 
publicly accessible data on drug use, health status, and mental health conditions among 
populations across the United States. This organization conducts a National survey and creates a 
codebook for the National Survey on Drug Use and Health (NSDUH) data. Previously, the 
survey was named the National Household Survey on Drug Abuse (NHSDA). The Center for 
Behavioral Health Statistics and Quality (CBHSQ) within SAMHSA, sponsors NSUDH. It is 
conducted by Research Triangle Park, North Carolina (SAMHSA, 2017). 
The survey codebook provides names of each variable, the variable description, the 
meaning of value codes, and an unweighted univariate frequency distribution results. The 
variables were mostly original interview items, except for a few changes that will later be 
discussed. Also, the directions for creating a subset of variables and the variable source and 
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recoding specifications are documented in the 2016 codebook. In addition, case ID interview 
date, computerized interview scores are included in this file. To an extent, the variable name 
indicates the variable meaning. Naming variables have been consistent across surveys when the 
content of questions is similar, or the specifications haven't changed. If variables don't have the 
same name across the years, there is an indication that they are existing differences. In this 
situation, analysts should examine the codebook file in detail before conducting any analysis 
(SAMHSA, 2017). 
Reasons for variable changes and recoding are found in the comments section found 
above the specific variable and the corresponding appendix file. Normally, if variables undergo 
any changes, they’re documented the same year they occur. However, the latest version may not 
always describe changes from prior years. Therefore, researchers interested in multiyear trends 
should familiarize themselves with the codebook report for all years of interest to identify any 
specific changes that could affect their results.  
NSDUH Overview 
 The 2016 NSDUH is the 36th in a series and is currently the primary method of 
measuring prevalence and social-relationships associated with drug use in the United States. This 
series of national surveys provide information on the use of illicit drugs, alcohol, and tobacco 
among members of the US civilian, who are noninstitutionalized and of age twelve years old and 
older. Also, the survey includes several sets of questions tailored to addressing mental health 
issues. Surveys have been conducted since 1971, with the earliest data provided on the 1979 
survey. In 1999, the survey underwent a complete redesign with additional improvements done 
in the 2002 survey.  
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In 1999, the method of data collection changed from a paper questionnaire administration 
to a computer-assisted administration to a computer-assisted administration. Alternatively, the 
updated survey design went from a strictly national design to including a state-to-state based 
sampling plan. Before 1999, the survey was done by using paper-and-pencil interviewing (PAPI) 
that lasted for about an hour. The PAPI technique included a questionnaire booklet completed by 
an interviewer and answer sheets completed by the respondent (SAMHSA, 2017). Sensitive 
substance use related questions appeared on the answer sheets, so the interviewer was unaware 
of the responses. The interviewer would ask less sensitive questions, such as demographics, the 
number of people in the home, highest completed educational level, employment status and 
others out loud and then record them in a questionnaire booklet (SAMHSA, 2017). 
Recently, the survey has been carried out using computer-assisted interviewing (CAI) 
methods. Currently, the survey uses a combination of computer-assisted personal interviewing 
(CAPI) conducted by an interviewer and audio computer assisted self-interviewing (ACASI) 
(SAMHSA, 2017). Using ACASI provides respondents with a highly private and confidential 
means of responding to questions and increases the level of honest reporting of illicit drug use 
and other sensitive behavior. Between 1999 and 2013 the survey sample was employed to 50-
state bases. The eight states with the largest population were labeled as large sample states 
(Florida, California, Illinois, Michigan, New York, Ohio, Pennsylvania, and Texas) with 
sampling size targets of 3,600 individuals. The 42 states remaining had a sampling target size of 
900 individuals (SAMHSA, 2017). 
The 2014-2017 sampling plan took on a more cost-efficient allocation for larger states 
while maintaining sufficient sample sizes in the smaller states (SAMHSA, 2017). The designed 
pan yielded “4,560 completed interviews in California; 3,300 completed interviews each in 
Rural Health Disparities Impact Opioid Use Disorders and Women45 
 
Florida, New York, and Texas; 2,400 completed interviews each in Illinois, Michigan, Ohio, and 
Pennsylvania; 1,500 completed interviews each in Georgia, New Jersey, North Carolina, and 
Virginia; 967 completed interviews in Hawaii; and 960 completed interviews in each of the 
remaining 37 states and the District of Columbia” (SAMHSA, 2017). Consistent with previous 
designs, the newer versions oversamples for youth age twelve years old to seventeen years old 
and young adults age 18 years old to 25 years old. However, the updated model places great 
emphasis on sampling the 26-year-old and older community. Ultimately, this will give a more 
accurate and realistic estimation of drug use and associated mental health measures. In the 2016 
sampling design, the following allocations were given: “twenty-five percent for youth age twelve 
years old to seventeen years old, twenty-five percent for young adults age eighteen years old to 
twenty-five years old, fifth-teen percent for adults age twenty-six to thirty-four years old, twenty 
percent for adults age thirty-five to forty-nine, and fifth-teen percent for adults age fifty and 
older” (SAMHSA, 2017). 
In addition to the 2002 survey name change, other changes such as giving each NSDUH 
respondent a $30 incentive to complete the survey made some improvements. The sample size 
achieved for the 2016 survey was 67, 942 individuals. “For each state sampling strata called state 
sampling regions (SSRs) were created and depending on, composite size measures, states were 
geographically split into approximately equal region sizes” (SAMHSA, 2017). This allowed each 
region within a state, to conduct the same amount of interview sessions during the data-
collection phase. “The United States was divided into a total of 750 SSRs, resulting in thirty-six 
SSRs from California; thirty SSRs in Florida, New York, and Texas; twenty-four SSRs in 
Illinois, Michigan, Ohio, and Pennsylvania; fifth-teen SSRs in North Carolina Georgia, Virginia, 
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and New Jersey; and twelve SSRs in the thirty-eight remaining states and the District of 
Columbia” (SAMHSA, 2017). 
Stage one of the selection process began with the construction of an area that contains 
one record for each census tract in the United States. Census tract data served as the primary 
sampling units (PSUs) for this survey design. “When necessary, aggregated census tracts were 
used within SSRs until each tract met the minimum dwelling unit (DU) requirement. The 
minimum DU requirement was 250 in urban areas and 200 DUs in rural areas, therefore the 
following states had 250: California, Florida, Georgia, Illinois, Michigan, New Jersey, New 
York, North Carolina, Ohio, Pennsylvania, Texas, and Virginia” (SAMHSA, 2017). The District 
of Columbia and remaining states followed guidelines for the minimum requirement which is 
150 DUs in urban areas and 100 DUs in rural areas. Overall, with survey-question alterations and 
updates regarding pain relievers, the survey has significantly improved its response rate since 
2002 (SAMHSA, 2017).  
Chapter IV: Methodology (quantitative and qualitative analysis) 
 To access the NSDUH data, I simply went on the SAMHSA website and downloaded the 
SPSS file to the computer. In addition, I also downloaded the SPSS software package, which is 
the Statistical Package for Social Sciences program. This data file was coded with each 
individual case (56,897 total participants) by rows, and all 2,664 variables were coded by 
columns. To familiarize myself with statistics and social science analyses techniques, I took an 
online SPSS course. This course was designed to provide the working-student community and 
research students with the skills to use SPSS on data of interest. Simultaneously while taking this 
course and performing classwork analysis, I ran the test through SPSS on my thesis data. This 
training better prepared me to tackle the vast 2016 NSDUH dataset that was not easily digestible. 
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  After organizing the data file into a more manageable format and identifying specific 
variables to be tested, I clustered them into three specific themes: Health, Risky behaviors, and 
Demographics. The selected variables for this project were chosen based on their relativeness to 
opioid use, specifically with women. The health theme included variables that addressed the 
overall health status, conditions, and or cost of healthcare, regarding opioid use. Risky behavior 
theme included any other drug or alcohol use and any criminal offenses or encounters with 
punishment from the law. The demographics theme included socioeconomic variables. For this 
study, opioid use was defined as any opium-derived prescription pain medicine, heroin, or illicit 
use of opioids in 2016. Rural locations were defined as areas with less than 100,000 residents, 
and urban areas were more than 100,000 residents. A mixed methods approach was implemented 
in this study because it provides better supportive veracity of the complex questions we 
addressed in this study. 
  Mixed method approaches consist of collecting data analysis from both quantitative and 
qualitative data for a single study. The data are collected concurrently or sequentially; for this 
study, we used a sequential approach. This method involves integrating all the data at one or 
more stages of the research process (Petrosyan, 2018).  There are several mixed methods designs 
commonly used among social scientists: convergent parallel design, explanatory sequential 
design, exploratory sequential design, and the embedded design. This essay will discuss three 
major types and elaborate on why they fit into this thesis.  
Convergent Parallel Design 
 Convergent parallel design is sometimes also called triangulation design. This means 
researchers use "concurrent timing" to incorporate quantitative and qualitative studies during the 
same phase of the research timeline. Both are equally important in addressing the research 
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problem, and both have equal priority during the process. However, this design keeps both 
studies independent during the "data collection and analysis" and "then matches the results of 
each analysis during the overall interpretation" (Petrosyan, 2018). The convergent design uses 
triangulated methods by directly comparing quantitative findings with qualitative results for 
validation and corroboration. This will ultimately help develop a complete clarification of a 
phenomenon. 
  Like all research efforts in the science world, each method has its advantages and 
disadvantages. The good thing about this design is that data can be collected and analyzed using 
each data's type of traditional techniques, which can be done at the same time. On the other hand, 
there are some challenges presented when using this approach.  Usually, each data type has an 
equal weight in the research design and requires much effort and expertise to collect. Forming a 
collaborative team of researchers to include members who have quantitative and qualitative 
expertise, is used to address the multiple disciplines integrated into the study. Researchers using 
this method should be aware of the consequences of having different samples that differ in size.  
Having different sample groups can cause difficulty when trying to merge data files for 
interpretations. Although the two separate data types produce meaningful results, contradictions 
that appear may give new insights to the problem but may require additional data to resolve.  
Explanatory Sequential Design 
  The name of this design gives way to the actual definition, which is this design uses 
sequential timing. To start the collection and analysis of quantitative data are given priority to 
addressing the study's problem. The second phase is to collect and analyze the qualitative data 
sequentially. Therefore, the qualitative format of the study is created to follow the results from 
the first quantitative analysis. Afterward, the researcher will interpret ways that the qualitative 
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findings explain results from the initial quantitative portion. The purpose of this design is to use 
quantitative findings to guide researchers to purposeful sampling for a qualitative stage 
(Petrosyan, 2018). 
  The benefits of this design are: it has a straightforward two-phase structure, where the 
researcher conducts the two methods in separate phases, and the initial phase can lend itself to 
"emergent approaches" for the second phase. The explanatory design is also more appealing to 
analysists because of its strong quantitative orientation. In addition, the challenges are a long-
time process for the researcher, difficulty with the Institutional Review Board (IRB) approval for 
the recruitment and participation selection, determining which quantitative results to explain 
further, and what criteria to use for the participants of the second phase. Therefore, field 
researchers can amalgamate their eclectic mix methods to aggrandize their studies' story.   
Exploratory Sequential Design 
 Like the explanatory design, exploratory uses sequential timing as well. However, the 
qualitative data collection and analysis phase is given priority first in exploratory. Building onto 
the qualitative results, the researcher conducts a quantitative second phase. This second phase 
tests the initial findings, and the researcher can then interpret their results. This design allows 
researchers to generalize information on a small sample to a larger population. Additionally, the 
first phase identifies critical variables for the second phase when variables are unknown. The 
phenomenon can be explored in depth, and the prevalence of its dimensions can be measured 
with this design. 
  Exploratory advantages are: describing, implantation, and reporting of this design is 
straightforward, and a new instrument can be formed as one of the potential yields of the 
research procedure. In contrast, the challenges are: it's a time-consuming research process, IRB 
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approval for the quantitative phase is difficult, to avoid bias, using small samples for the first 
phase and a larger sample for the second phase should be considered, and investigators should be 
meticulous about the scores produced from the instrument, so the study's story is bolstered and 
not enervated by biases.  
  The foundation of this thesis work is based on the mixed methods approach. Of the above 
designs, this project has incorporated the concepts of convergent, exploratory, and explanatory 
techniques to address opioid use among adult females. The following variables were identified as 
necessary through quantitative analysis and should be further explored during a qualitative 
phase: income, race, education, poverty, drug treatment services, occupational status, resource 
access, drug types and usage, criminal history, and health status. This led to the descriptive 
testing which lends itself to the second qualitative analysis phase.  
First, in the quantitative analysis phase, frequency distribution tables were produced. 
Then chi-square independence test on cross-tabulations of the variables was run on all the 
variables and the corresponding p-values were recorded and interpreted. For organizational 
purposes, variables proven to have some relationship with the opioid user subpopulation are 
included in the results section, and non-related variables can be found in the appendix section. 
Qualitative analysis of the rural North Georgia/Southern Appalachia area to support findings 
from the initial first phase. An IRB application was created and approved (Study #: 19-021) 
through KSU. Once approved for one-on-one interviews, a list of professional healthcare 
contacts in the North Georgia area was used for recruitment. Interviews were conducted using a 
"snowball" contact approach, and interviews were carried out until theoretical saturation was 
reached. 
Chapter V: Results 
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 The following section includes tables of findings from the variables analyzed during the 
first phase. The variables derived from the NSDUH 2016 report are available through the 
SAMHSA website. In this dataset, there are 56,897 total responds and of that 22,772 are adult 
females (18 years old and older). Further investigating determined there are a total of 1,133 adult 
females who reported misusing opioids in this survey. Because we were specifically interested in 
rural women, the following groups (of the 22,772 cases) were created for analysis: urban or no 
rural females without opioid past year misuse (coded as NRNO), urban or no rural females with 
past year opioid use (coded as NRO), and rural females without opioid misuse (coded as RNO, 
and rural females with opioid past year misuse (coded as RO). 
  A total of 85 variables were utilized from the NSDUH, including a combined re-coded 
variable for location and opioid misuse. Out of the 85 variables, only 26 have statistically 
significant results and show apparent differences between the rural and urban locations. The 
remainder 57 variables include the following: the number of employers in the past year, overall 
health insurance coverage, participant in the US Armed Forces, parole, ever been arrested and 
booked, ever stayed in the hospital overnight in the past year, welfare/childcare help, reason for 
misusing pain medication, if your religious beliefs are important, cancer, cirrhosis of the liver, 
kidney disease, chronic bronchitis, asthma, tramadol use, oxycodone use, hydrocodone use, 
OxyContin use, Oxymorphone use, buprenorphine use, fentanyl use, morphine, codeine,  
methadone, hydromorphone, Demerol, employment status, sold illegal drugs, HIV/AIDS, heroin 
or pain medication use, income, education, smoked heroin, sniffed heroin, used cocaine with last 
alcohol drink, used heroin with last alcohol drink, how difficult is it to obtain crack, probation, 
treatment in a private doctors office, heart condition, sugar diabetes, high blood pressure, tried to 
kill yourself, difficulty hearing, difficulty seeing, difficulty dressing and bathing, difficulty doing 
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errands alone, Medicare, written drug policy at work, family receives SSI, it is important for 
your friends to share the same religious beliefs, number of persons in the HH, number of children 
in the house under 18 years old, number of persons 65 years or older in HH, was the interview 
too long, and was the interview hard to understand. These 58 variables have no statistical 
significance and show no difference between rural and urban locations.   
Variable Theme 1: Health 
 
Graph 1: Received treatment in prison or jail. This bar chart represents the percentage of female 
respondents in this survey. There are four groups: urban-w/o (yellow) means they are just a 
urban resident who is not misusing opioids, urban-yes (blue) means they are a urban resident and 
misuse opioids, rural-w/o means (red) they are just a rural resident, and rural-yes (purple) means 
they are a rural resident and misuse opioids. The statistics show there is a relationship and rural 
female users are unique compared to their urban counterparts. *p-value vs. urban. The graph was 
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Graph 2: Trouble leaving the house, due to emotional issues. This bar chart represents the 
percentage of female respondents in this survey. There are four groups: urban-w/o (yellow) 
means they are just a urban resident who is not misusing opioids, urban-yes (blue) means they 
are a urban resident and misuse opioids, rural-w/o means (red) they are just a rural resident, and 
rural-yes (purple) means they are a rural resident and misuse opioids. The statistics show there is 
a relationship and rural female users are unique compared to their urban counterparts. *p-value 
vs. urban. The graph was generated using Graph-Pad prism 7. 
 
Graph 3: Serious difficulty remembering and concentrating. This bar chart represents the 
percentage of female respondents in this survey. There are four groups: urban-w/o (yellow) 
means they are just a urban resident who is not misusing opioids, urban-yes (blue) means they 
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rural-yes (purple) means they are a rural resident and misuse opioids. The statistics show there is 
a relationship and rural female users are unique compared to their urban counterparts. *p-value 
vs. urban. The graph was generated using Graph-Pad prism 7. 
 
Graph 4: Serious difficulty walking or climbing. This bar chart represents the percentage of 
female respondents in this survey. There are four groups: urban-w/o (yellow) means they are just 
a urban resident who is not misusing opioids, urban-yes (blue) means they are a urban resident 
and misuse opioids, rural-w/o means (red) they are just a rural resident, and rural-yes (purple) 
means they are a rural resident and misuse opioids. The statistics show there is a relationship and 
rural female users are unique compared to their urban counterparts. *p-value vs. urban. The 
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Graph 5: Medicaid coverage. This bar chart represents the percentage of female respondents in 
this survey. There are four groups: urban-w/o (yellow) means they are just a urban resident who 
is not misusing opioids, urban-yes (blue) means they are a urban resident and misuse opioids, 
rural-w/o means (red) they are just a rural resident, and rural-yes (purple) means they are a rural 
resident and misuse opioids. The statistics show there is a relationship and rural female users are 
unique compared to their urban counterparts. *p-value vs. urban. The graph was generated using 
Graph-Pad prism 7. 
 
Graph 6: private health insurance coverage. This bar chart represents the percentage of female 
respondents in this survey. There are four groups: urban-w/o (yellow) means they are just a 
urban resident who is not misusing opioids, urban-yes (blue) means they are a urban resident and 
misuse opioids, rural-w/o means (red) they are just a rural resident, and rural-yes (purple) means 
they are a rural resident and misuse opioids. The statistics show there is a relationship and rural 
female users are unique compared to their urban counterparts. *p-value vs. urban. The graph was 










Are you covered by private health insurance




















Rural Health Disparities Impact Opioid Use Disorders and Women56 
 
Graph 7: Treatment from overnight stay at the hospital. This bar chart represents the percentage 
of female respondents in this survey. There are four groups: urban-w/o (yellow) means they are 
just a urban resident who is not misusing opioids, urban-yes (blue) means they are a urban 
resident and misuse opioids, rural-w/o means (red) they are just a rural resident, and rural-yes 
(purple) means they are a rural resident and misuse opioids. The statistics show there is a 
relationship and rural female users are unique compared to their urban counterparts. *p-value vs. 
urban. The graph was generated using Graph-Pad prism 7. 
 
Graph 8: Treatment in rehab center. This bar chart represents the percentage of female 
respondents in this survey. There are four groups: urban-w/o (yellow) means they are just a 
urban resident who is not misusing opioids, urban-yes (blue) means they are a urban resident and 
misuse opioids, rural-w/o means (red) they are just a rural resident, and rural-yes (purple) means 
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female users are unique compared to their urban counterparts. *p-value vs. urban. The graph was 
generated using Graph-Pad prism 7. 
 
Graph 9: Treatment in mental health center. This bar chart represents the percentage of female 
respondents in this survey. There are four groups: urban-w/o (yellow) means they are just a 
urban resident who is not misusing opioids, urban-yes (blue) means they are a urban resident and 
misuse opioids, rural-w/o means (red) they are just a rural resident, and rural-yes (purple) means 
they are a rural resident and misuse opioids. The statistics show there is a relationship and rural 
female users are unique compared to their urban counterparts. *p-value vs. urban. The graph was 
generated using Graph-Pad prism 7. 
 
Graph 10: Hepatitis B or C condition. This bar chart represents the percentage of female 
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urban resident who is not misusing opioids, urban-yes (blue) means they are a urban resident and 
misuse opioids, rural-w/o means (red) they are just a rural resident, and rural-yes (purple) means 
they are a rural resident and misuse opioids. The statistics show there is a relationship and rural 
female users are unique compared to their urban counterparts. *p-value vs. urban. The graph was 
generated using Graph-Pad prism 7. 
 
Graph 11: Have you ever received alcohol or drug treatment. This bar chart represents the 
percentage of female respondents in this survey. There are four groups: urban-w/o (yellow) 
means they are just a urban resident who is not misusing opioids, urban-yes (blue) means they 
are a urban resident and misuse opioids, rural-w/o means (red) they are just a rural resident, and 
rural-yes (purple) means they are a rural resident and misuse opioids. The statistics show there is 
a relationship and rural female users are unique compared to their urban counterparts. *p-value 
vs. urban. The graph was generated using Graph-Pad prism 7. 
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Graph 12: Age. This bar chart represents the percentage of female respondents in this survey. 
There are four groups: urban-w/o (yellow) means they are just a urban resident who is not 
misusing opioids, urban-yes (blue) means they are a urban resident and misuse opioids, rural-w/o 
means (red) they are just a rural resident, and rural-yes (purple) means they are a rural resident 
and misuse opioids. The statistics show there is a relationship and rural female users are unique 
compared to their urban counterparts. *p-value vs. urban. The graph was generated using Graph-
Pad prism 7. 
 
Graph 13: Food stamps benefits for the family/respondent. This bar chart represents the 
percentage of female respondents in this survey. There are four groups: urban-w/o (yellow) 
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are a urban resident and misuse opioids, rural-w/o means (red) they are just a rural resident, and 
rural-yes (purple) means they are a rural resident and misuse opioids. The statistics show there is 
a relationship and rural female users are unique compared to their urban counterparts. *p-value 
vs. urban. The graph was generated using Graph-Pad prism 7. 
 
Graph 14: Religion influences decisions. This bar chart represents the percentage of female 
respondents in this survey. There are four groups: urban-w/o (yellow) means they are just a 
urban resident who is not misusing opioids, urban-yes (blue) means they are a urban resident and 
misuse opioids, rural-w/o means (red) they are just a rural resident, and rural-yes (purple) means 
they are a rural resident and misuse opioids. The statistics show there is a relationship and rural 
female users are unique compared to their urban counterparts. *p-value vs. urban. The graph was 
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Graph 15: Marital status. This bar chart represents the percentage of female respondents in this 
survey. There are four groups: urban-w/o (yellow) means they are just a urban resident who is 
not misusing opioids, urban-yes (blue) means they are a urban resident and misuse opioids, rural-
w/o means (red) they are just a rural resident, and rural-yes (purple) means they are a rural 
resident and misuse opioids. The statistics show there is a relationship and rural female users are 
unique compared to their urban counterparts. *p-value vs. urban. The graph was generated using 














































Rural Health Disparities Impact Opioid Use Disorders and Women62 
 
 
Graph 16: Sexual preference. This bar chart represents the percentage of female respondents in 
this survey. There are four groups: urban-w/o (yellow) means they are just a urban resident who 
is not misusing opioids, urban-yes (blue) means they are a urban resident and misuse opioids, 
rural-w/o means (red) they are just a rural resident, and rural-yes (purple) means they are a rural 
resident and misuse opioids. The statistics show there is a relationship and rural female users are 
unique compared to their urban counterparts. *p-value vs. urban. The graph was generated using 
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Graph 17: Family needed government assistance. This bar chart represents the percentage of 
female respondents in this survey. There are four groups: urban-w/o (yellow) means they are just 
a urban resident who is not misusing opioids, urban-yes (blue) means they are a urban resident 
and misuse opioids, rural-w/o means (red) they are just a rural resident, and rural-yes (purple) 
means they are a rural resident and misuse opioids. The statistics show there is a relationship and 
rural female users are unique compared to their urban counterparts. *p-value vs. urban. The 
graph was generated using Graph-Pad prism 7. 
 
Graph 18: Race. This bar chart represents the percentage of female respondents in this survey. 
There are four groups: urban-w/o (yellow) means they are just a urban resident who is not 
misusing opioids, urban-yes (blue) means they are a urban resident and misuse opioids, rural-w/o 
means (red) they are just a rural resident, and rural-yes (purple) means they are a rural resident 
and misuse opioids. The statistics show there is a relationship and rural female users are unique 
compared to their urban counterparts. *p-value vs. urban. The graph was generated using Graph-
Pad prism 7. 
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Graph 19: Approached by someone selling drugs. This bar chart represents the percentage of 
female respondents in this survey. There are four groups: urban-w/o (yellow) means they are just 
a urban resident who is not misusing opioids, urban-yes (blue) means they are a urban resident 
and misuse opioids, rural-w/o means (red) they are just a rural resident, and rural-yes (purple) 
means they are a rural resident and misuse opioids. The statistics show there is a relationship and 
rural female users are unique compared to their urban counterparts. *p-value vs. urban. The 
graph was generated using Graph-Pad prism 7. 
 
Graph 20: How old were you when you had your first alcohol drink. This bar chart represents 
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means they are just a urban resident who is not misusing opioids, urban-yes (blue) means they 
are a urban resident and misuse opioids, rural-w/o means (red) they are just a rural resident, and 
rural-yes (purple) means they are a rural resident and misuse opioids. The statistics show there is 
a relationship and rural female users are unique compared to their urban counterparts. *p-value 
vs. urban. The graph was generated using Graph-Pad prism 7. 
 
Graph 21: How difficult is it to obtain marijuana. This bar chart represents the percentage of 
female respondents in this survey. There are four groups: urban-w/o (yellow) means they are just 
a urban resident who is not misusing opioids, urban-yes (blue) means they are a urban resident 
and misuse opioids, rural-w/o means (red) they are just a rural resident, and rural-yes (purple) 
means they are a rural resident and misuse opioids. The statistics show there is a relationship and 
rural female users are unique compared to their urban counterparts. *p-value vs. urban. The 
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Graph 22: How difficult is it to obtain cocaine. This bar chart represents the percentage of 
female respondents in this survey. There are four groups: urban-w/o (yellow) means they are just 
a urban resident who is not misusing opioids, urban-yes (blue) means they are a urban resident 
and misuse opioids, rural-w/o means (red) they are just a rural resident, and rural-yes (purple) 
means they are a rural resident and misuse opioids. The statistics show there is a relationship and 
rural female users are unique compared to their urban counterparts. *p-value vs. urban. The 
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Graph 23: How old were you when you first tried marijuana. This bar chart represents the 
percentage of female respondents in this survey. There are four groups: urban-w/o (yellow) 
means they are just a urban resident who is not misusing opioids, urban-yes (blue) means they 
are a urban resident and misuse opioids, rural-w/o means (red) they are just a rural resident, and 
rural-yes (purple) means they are a rural resident and misuse opioids. The statistics show there is 
a relationship and rural female users are unique compared to their urban counterparts. *p-value 
vs. urban. The graph was generated using Graph-Pad prism 7. 
 
 
Graph 24: Enjoy risky behaviors. This bar chart represents the percentage of female respondents 
in this survey. There are four groups: urban-w/o (yellow) means they are just a urban resident 
who is not misusing opioids, urban-yes (blue) means they are a urban resident and misuse 
opioids, rural-w/o means (red) they are just a rural resident, and rural-yes (purple) means they 
are a rural resident and misuse opioids. The statistics show there is a relationship and rural 
female users are unique compared to their urban counterparts. *p-value vs. urban. The graph was 
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Graph 25: Marijuana and alcohol use. This bar chart represents the percentage of female 
respondents in this survey. There are four groups: urban-w/o (yellow) means they are just a 
urban resident who is not misusing opioids, urban-yes (blue) means they are a urban resident and 
misuse opioids, rural-w/o means (red) they are just a rural resident, and rural-yes (purple) means 
they are a rural resident and misuse opioids. The statistics show there is a relationship and rural 
female users are unique compared to their urban counterparts. *p-value vs. urban. The graph was 
generated using Graph-Pad prism 7. 
 
Graph 26: Heroin access difficulty. This bar chart represents the percentage of female 
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urban resident who is not misusing opioids, urban-yes (blue) means they are a urban resident and 
misuse opioids, rural-w/o means (red) they are just a rural resident, and rural-yes (purple) means 
they are a rural resident and misuse opioids. The statistics show there is a relationship and rural 
female users are unique compared to their urban counterparts. *p-value vs. urban. The graph was 
generated using Graph-Pad prism 7. 
Matching qualitative theme quotes 
Health 
– “There are 15 facilities in North GA focused on opioid addiction, but we only hear about 
two”… 
– Two places (one on KSU campus and the other in Marietta) 
– “Transportation issues are common disconnects among drug/alcohol programs and 
users”… 
– “We know nothing about the quality of these programs and their success rates”… 
– “Rural areas lack adequate healthcare programs, hospitals, etc.”… 
– “Women have to work multiple jobs to support their family and their habits”… 
– “Doctor shopping”… 
– “Pharmacies are not doing a good job of tracking prescription orders across 
locations/businesses”… 
– “Throwing money at the opioid epidemic won’t fix-it, we need more action and 
community engagement”… “The policy needs to be changed…” 
Demographics 
– “Focus on childbearing age 12-44 years old”… 
– “Heroin casual use is more prevalent among younger group”… 
– “Prescription opioids misuse is more common among older/senior adults”… 
– “Heroin is the cheaper option”… 
– “The aging community depend on and trust their primary doctor and local pharmacies”… 
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– “I can’t get addicted because the doctor prescribed the medication”… 
– “Predominately a white community issue”… 
– “We don’t hear anything about other races and their opioid use…the research is not 
there”… 
– Treatment- “90% white and then the others”… 
– Researcher- “55% white and then the others”… 
– Prevention- “23% white and then the others”… 
– “The women I work with are 50% African American and 50% Hispanic…but we don’t 
anything about these populations until NAS”… 
Risky behaviors 
– “Women are often seen as dirty or shunned because of their drug use”… 
– “Prescription pain killers lead to heroin use- heroin is the cheaper option”… 
– “Women have the most access to medications in the house because they’re in charge of 
storage and usually give medicine to sick or ill children”… 
Overall, health, demographics and risky behaviors variables or questions, which includes poly-
drug use, were analyzed at both the quantitative and qualitative level. Some variables were 
originally viewed from just the NSDUH dataset, however other variables were used based on the 
insight provided from the qualitative interview phase of the study.  
 
 
Chapter VI: Discussion 
 The purpose of this study was to identify and investigate social factors that could 
potentially be the underlying driving influential factors for increased opioid use. Rarely do 
researchers focus specifically on the female subpopulation nor the rural communities. The lack 
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of evidence-based and research data-driven studies on these vulnerable populations have made it 
extremely difficult to characterize these groups. The work conducted in this study has provided 
some insight to the vulnerable populations that are overlooked in the science and health field. 
 The following variables have been identified as having some relationship to opioid 
misuse among the female population: income, race, education, poverty, drug treatment services, 
occupational status, resource access, drug types and usage, criminal history, and health status. 
Tables of the cross-tabulation and chi-square p-value data have been provided in the results 
section of this essay. Based on the results, rural female opioid users tends to affect less poor 
women. It tends to affect women who have some college education the most. White rural female 
opioid users tend to be disproportionately affected compared to other races such as blacks and 
Hispanics. Almost half of the female opioid users have utilized government assistance programs. 
Prescription pain reliever use only resulted in the highest percent for opioid misuse among rural 
females. Most of the rural females reported working full time. Interestingly, not many rural 
female opioid users reported receiving drug or alcohol treatment. In conclusion of the first phase 
of this study, rural females are most likely to experience opioid use differently from men and 
their urban-female counterparts. This sets a foundation for the need for special attention to be 
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Appendix:  
Percentage charts from Graph-pad prism 7 
 All females NRNO NRO RNO RO 
In poverty 27% 20% 26% 23.3% 33% 
2X 
poverty 
23% 21.6% 22% 26.0% 29% 
More than 
2X 
49% 58.4% 52% 50.7% 38% 
Missing 1% 0% 0% 0% 0% 
Total 100% 100% 100% 100% 100% 
Chart 1: P-value = .000 (alpha = .05). In addition, (1.2%) are missing. Poverty status: Female 
opioid user’s n = 1,133 total. The following percent are for the overall adult female population: 
27% in poverty, 23% 2X pov, 49%, more than 2X pov, and 1% missing. This table displays the 
quantitative data from the poverty variable in the NSDUH. The variable asks about poverty 
status and has three categories: in poverty, making 2X the federal poverty threshold, and making 
more than 2X the federal poverty threshold. The “all females” column represents all the adult 
females (22,772) in the survey. One percent of this subpopulation didn’t report their status. 
NRNO is the urban and non-opioid group (control group), NRO is the urban opioid users, RNO 
is the rural non-opioid group, and RO is the rural opioid users. P0.05.  
 All females NRNO NRO RNO RO 
Less than 
HS 
11.7% 11.5% 12.1% 12.3% 15% 
HS 24.2% 23% 25.2% 28.8% 28.5% 
Some 
college 
36.1% 35.3% 39.5% 38.3% 40.2% 
College 
Grad 
28% 30.2% 23.2% 20.6% 16.3% 
Total 100% 100% 100% 100% 100% 
Chart 2: P-value = .000 (alpha = .05). Education level: Female opioid user’s n = 1,133 total. The 
following percent are for the overall adult female population: 11.7% less than HS, 24.2% HS, 
36.1% some college, and 28% college grads. This table displays the quantitative data from the 
education variable in the NSDUH. The variable asks about education levels and has four 
categories: less than high-school, high-school diploma, some college, and college graduate. The 
“all females” column represents all the adult females (22,772) in the survey. NRNO is the urban 
and non-opioid group (control group), NRO is the urban opioid users, RNO is the rural non-
opioid group, and RO is the rural opioid users. P0.05.  
 All females NRNO NRO RNO RO 
White 60.2% 56.1% 63.3% 76.2% 73.4% 
Black 13.2% 15% 11.5% 7.7% 5.6% 
Hispanic 17% 19.3% 16.6% 7.3% 6.5% 
Other 9.6% 9.6% 8.6% 8.8% 14.5% 
Total 100% 100% 100% 100% 100% 
Table 3: P-value = .000 (alpha = .05). Race: Female opioid user’s n = 1,133 total. The following 
percent are for the overall adult female population: 60.2% white, 13.2% black, 17.0% Hispanic, 
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and 9.6% other. This table displays the quantitative data from the race variable in the NSDUH. 
The variable asks about the racial background and has four categories: white, black, Hispanic, 
and other. The “all females” column represents all the adult females (22,772) in the survey. 
NRNO is the urban and non-opioid group (control group), NRO is the urban opioid users, RNO 
is the rural non-opioid group, and RO is the rural opioid users. P0.05.  
 All females NRNO NRO RNO RO 
Less than 
20k 
23% 21.5% 28% 26.4% 35% 
20-49k 32% 31% 34% 36% 40.2% 
50-74k 15.2% 15.3% 15.5% 15% 9% 
More than 
75k 
29.8% 32.2% 22.5% 22.6% 15.8% 
Total 100% 100% 100% 100% 100% 
Chart 4: P-value = .000 (alpha = .05). Income: Female opioid user’s n = 1,133 total. The 
following percent are for the overall adult female population: 23% less than $20,000, 32% $20-
49,999, 15.2% $50-74,999, and 29.8% reported making over $75,000. This table displays the 
quantitative data from the income variable in the NSDUH. The variable asks about poverty status 
and has four categories: less than $20,000, $20,999-49,999, $50,000-74,999, and more than 
$75,000. The “all females” column represents all the adult females (22,772) in the survey. 
NRNO is the urban and non-opioid group (control group), NRO is the urban opioid users, RNO 
is the rural non-opioid group, and RO is the rural opioid users. P0.05.  
 All females NRNO NRO RNO RO 
Yes 24.4% 23% 34% 27% 44.4% 
No 75.6% 77% 66% 73% 55.6% 
Total 100% 100% 100% 100% 100% 
Chart 5: P-value = .000 (alpha = .05). Government assistance programs. Female opioid user’s n 
= 1,133 total. The following percent are for the overall adult female population: 24.4% yes and 
75.6% said no. This table displays the quantitative data from the participation in one or more 
government assistance programs variable in the NSDUH. The variable asks about participation 
in the government assistance programs and has two categories: “yes” and “no”. The “all 
females” column represents all the adult females (22,772) in the survey. NRNO is the urban and 
non-opioid group (control group), NRO is the urban opioid users, RNO is the rural non-opioid 
group, and RO is the rural opioid users. P0.05.  
 All females NRNO NRO RNO RO 
Heroin 
only 
0.1% 0% 2.5% 0% 2.3% 
PNR only 4.6% 0% 92% 0% 91.1% 
Both 0.3% 0% 5.5% 0% 6.6% 
None 95% 100% 0% 100% 0% 
Total 100% 100% 100% 100% 100% 
Chart 6: P-value = .000 (alpha = .05). Heroin and Pain reliever misuse in the past year. Female 
opioid user’s n = 1,133 total. The following percent are for the overall adult female population: 
0.1% heroin only, 4.6% PNR only, 0.3% both, and 95% none. This table displays the quantitative 
data from the heroin and pain reliever misuse (in 2016) variable in the NSDUH. The variable 
asks about the misuse of heroin and pain relievers in the past year and has four categories: heroin 
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only, pain reliever only, both, and none. The “all females” column represents all the adult 
females (22,772) in the survey. NRNO is the urban and non-opioid group (control group), NRO 
is the urban opioid users, RNO is the rural non-opioid group, and RO is the rural opioid users. 
P0.05.  
 All females NRNO NRO RNO RO 
Yes 0.3% 0.3% 1.2% 0.1% 0% 
No 99.7% 99.7% 98.8% 99.9% 100% 
Total 100% 100% 100% 100% 100% 
Chart 7: P-value = .010 (alpha = .05). Female opioid user’s n = 1,133 total. The following 
percent are for the overall adult female population: Ever been told you had HIV/AIDS: 0.3% yes 
and 99.7% no. This table displays the quantitative data from the HIV/AIDS variable in the 
NSDUH. The variable asks, “Have you ever been told you had HIV/AIDS” and has two 
categories: “yes” and “no”. The “all females” column represents all the adult females (22,772) in 
the survey. NRNO is the urban and non-opioid group (control group), NRO is the urban opioid 
users, RNO is the rural non-opioid group, and RO is the rural opioid users. P0.05.  
 All 
females 
NRNO NRO RNO RO 
Zero times 98.6% 99% 91.5% 99% 88.8% 
1-2 0.8% 0.6% 3.8% 0.6% 4.2% 
3-5 0.2% 0.1% 1.7% 0.1% 2.3% 
6-9 0.1% 0.1% 1.3% 0.1% 0.5% 
10 or more 0.3% 0.2% 1.7% 0.2% 4.2% 
Total 100% 100% 100% 100% 100% 
Chart 8: P-value = .000 (alpha = .05). The following percent are for the overall adult female 
population: Sold illegal drugs 98.6% zero times, 0.8% one or two times, 0.2% three to five times, 
0.1% six to nine times, and 0.3% ten or more times. This table displays the quantitative data 
from the “ever sold illegal drugs” variable in the NSDUH. The variable asks, “have you ever 
sold illegal drugs” and has five categories: zero-times, 1-2 times, 3-5 times, 6-9 times, and 10 or 
more times. The “all females” column represents all the adult females (22,772) in the survey. 
NRNO is the urban and non-opioid group (control group), NRO is the urban opioid users, RNO 
is the rural non-opioid group, and RO is the rural opioid users. P0.05.  
 All females NRNO NRO RNO RO 
Full time 45.2% 45.7% 49.1% 42.1% 41.5% 
Part-time 19% 19% 19% 18% 15.4% 
Unemployment 5.0% 5.2% 7% 4.4% 11.3% 
Other 30.8% 30.1% 24.9% 35.5% 31.8% 
Total 100% 100% 100% 100% 100% 
Chart 9: P-value = .000 (alpha = .05). The following percent are for the overall adult female 
population: Employment status 45.2% full-time, 19.0% part-time, 5.0% unemployment, and 
30.8% for the other category. This table displays the quantitative data from the employment 
variable in the NSDUH. The variable asks about employment status and has four categories: full-
time, part-time, unemployment, and the other category. The "all females" column represents all 
the adult females (22,772) in the survey. NRNO is the urban and non-opioid group (control 
group), NRO is the urban opioid users, RNO is the rural non-opioid group, and RO is the rural 
opioid users. P0.05.  
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 All females NRNO NRO RNO RO 
Yes 5.4% 4.1% 21.1% 5.4% 21.5% 
No 94.6% 95.9% 78.9% 94.6% 78.5% 
Total 100% 100% 100% 100% 100% 
Chart 10: P-value = .000 (alpha = .05). The following percent are for the overall adult female 
population: Ever received alcohol or drug treatment is 5.4%, yes and 94.6% said no. This table 
displays the quantitative data from the alcohol and or drug treatment variable in the NSDUH. 
The variable asks, “Have you ever received alcohol or drug treatment” and has two categories: 
“yes” and “no”. The “all females” column represents all the adult females (22,772) in the survey. 
NRNO is the urban and non-opioid group (control group), NRO is the urban opioid users, RNO 
is the rural non-opioid group, and RO is the rural opioid users. P0.05.  
 All females NRNO NRO RNO RO 
> 14 9% 8% 28% 8% 32% 
15-17 18.4% 18% 31.4% 17% 35% 
18+ 20.0% 20.3% 20% 19.1% 18% 
Non-user 52.6% 53.7% 20.6% 55.9% 15% 
Total 100% 100% 100% 100% 100% 
Chart 11: Age of first marijuana use P-value = .000 (alpha = .05). The following percent are for 
the overall adult female population: Age of first marijuana use for all females is 9% less than 14 
years old, 18.4% for between ages 15-17 years old, 20% for the 18 and older group, and 52.6% 
for the non-user group. This table displays the quantitative data from the alcohol and or drug 
treatment variable in the NSDUH. The variable asks, “Age of first marijuana use” and has four 
categories. The “all females” column represents all the adult females (22,772) in the survey. 
NRNO is the urban and non-opioid group (control group), NRO is the urban opioid users, RNO 
is the rural non-opioid group, and RO is the rural opioid users. P0.05. 
 All females NRNO NRO RNO RO 
Easy 64.8% 64% 84% 64% 85.9% 
Not easy 35.2% 36% 16% 36% 14.1% 
Total 100% 100% 100% 100% 100% 
Chart 12: Difficulty to obtain marijuana. P-value = .000 (alpha = .05). The following percent are 
for the overall adult female population: “How difficult is it to obtain marijuana” for all females, 
64.8% said it was easy to obtain and 35.2% said it was difficult to obtain. This table displays the 
quantitative data from the “how difficult is it to obtain marijuana” variable in the NSDUH and 
has two categories or answer options. The “all females” column represents all the adult females 
(22,772) in the survey. NRNO is the urban and non-opioid group (control group), NRO is the 
urban opioid users, RNO is the rural non-opioid group, and RO is the rural opioid users. P0.05. 
 All females NRNO NRO RNO RO 
Easy 21% 20% 27% 22% 31% 
Not easy 79% 80% 73% 78% 69% 
Total 100% 100% 100% 100% 100% 
Chart 13: Difficulty to obtain crack… Difficulty to obtain crack-cocaine. P-value = .000 (alpha 
= .05). The following percent’s are for the overall adult female population: “How difficult is it to 
obtain crack” for all females, 21% said it was easy to obtain and 79% said it was difficult to 
obtain. This table displays the quantitative data from the “how difficult is it to obtain crack” 
variable in the NSDUH and has two categories or answer options. The “all females” column 
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represents all the adult females (22,772) in the survey. NRNO is the urban and non-opioid group 
(control group), NRO is the urban opioid users, RNO is the rural non-opioid group, and RO is 
the rural opioid users. P0.05. 
 All females NRNO NRO RNO RO 
Easy 25% 25% 40.8% 23% 39% 
Not easy 75% 75% 59.2% 77% 61% 
Total 100% 100% 100% 100% 100% 
Chart 14: Difficulty to obtain cocaine… Difficulty to obtain cocaine. P-value = .000 (alpha = 
.05). The following percent’s are for the overall adult female population: “How difficult is it to 
obtain cocaine” for all females, 25% said it was easy to obtain and 75% said it was difficult to 
obtain. This table displays the quantitative data from the “how difficult is it to obtain cocaine” 
variable in the NSDUH and has two categories or answer options. The “all females” column 
represents all the adult females (22,772) in the survey. NRNO is the urban and non-opioid group 
(control group), NRO is the urban opioid users, RNO is the rural non-opioid group, and RO is 
the rural opioid users. P0.05. 
 All females NRNO NRO RNO RO 
Yes 0.04% 0% 1% 0% 2% 
No 99.96% 100% 99% 100% 98% 
Total 100% 100% 100% 100% 100% 
Chart 15: Any Demerol past year misuse… Any Demerol use in the past year (2016). P-value = 
.000 (alpha = .05). The following percent’s are for the overall adult female population: “Any 
Demerol use in the past year (2016)” for all females, 0.04% said “yes” and 99.6% said “no”. 
This table displays the quantitative data from the “Any Demerol use in the past year (2016)” 
variable in the NSDUH and has two categories or answer options. The “all females” column 
represents all the adult females (22,772) in the survey. NRNO is the urban and non-opioid group 
(control group), NRO is the urban opioid users, RNO is the rural non-opioid group, and RO is 
the rural opioid users. P0.05. 
 All females NRNO NRO RNO RO 
Yes 0.1% 0% 1.5% 0% 4% 
No 99.9% 100% 98.5% 100% 96% 
Total 100% 100% 100% 100% 100% 
Chart 16: Any Hydromorphone past year misuse… Any Hydromorphone past year misuse… 
Any Hydromorphone use in the past year (2016). P-value = .000 (alpha = .05). The following 
percent’s are for the overall adult female population: “Any Hydromorphone use in the past year 
(2016)” for all females, 0.1% said “yes” and 99.9% said “no”. This table displays the 
quantitative data from the “Any Hydromorphone use in the past year (2016)” variable in the 
NSDUH and has two categories or answer options. The “all females” column represents all the 
adult females (22,772) in the survey. NRNO is the urban and non-opioid group (control group), 
NRO is the urban opioid users, RNO is the rural non-opioid group, and RO is the rural opioid 
users. P0.05. 
 All females NRNO NRO RNO RO 
> 14 15% 13.5% 36.3% 15.3% 40.2% 
15-17 31% 30% 38.5% 32% 40% 
18-20 22% 23% 13.1% 22% 11% 
21+ 17% 18% 8.3% 16% 5.1% 
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Non-user 15% 15.5% 3.8% 14.7% 3.7% 
Total 100% 100% 100% 100% 100% 
Chart 17: Age of first Alcohol use… Age of first Alcohol use. P-value = .000 (alpha = .05). The 
following percent’s are for the overall adult female population: “Age of first Alcohol use in the 
past year (2016)” for all females, age 14 years old and younger, 15% responded to this age 
group, 31% of all females responded to the age group 15-17 years old, 22% of all the females 
responded to the age group 18-20, and 17% of all females responded to being 21 years old or 
older when they had their first alcohol beverage. This table displays the quantitative data from 
the “Age of first alcohol use” variable in the NSDUH and has five categories or answer options. 
The “all females” column represents all the adult females (22,772) in the survey. NRNO is the 
urban and non-opioid group (control group), NRO is the urban opioid users, RNO is the rural 
non-opioid group, and RO is the rural opioid users. P0.05. 
 All females NRNO NRO RNO RO 
Yes 0.2% 0% 3.2% 0% 5% 
No 99.8% 100% 96.8% 100% 95% 
Total 100% 100% 100% 100% 100% 
Chart 18: Any Methadone past year misuse (2016)… Any Methadone use in the past year 
(2016). P-value = .000 (alpha = .05). The following percent’s are for the overall adult female 
population: “Any Methadone use in the past year (2016)” for all females, 0.2% said “yes” and 
99.8% said “no”. This table displays the quantitative data from the “Any Methadone use in the 
past year (2016)” variable in the NSDUH and has two categories or answer options. The “all 
females” column represents all the adult females (22,772) in the survey. NRNO is the urban and 
non-opioid group (control group), NRO is the urban opioid users, RNO is the rural non-opioid 
group, and RO is the rural opioid users. P0.05. 
 All females NRNO NRO RNO RO 
Yes 10.3% 0% 21.5% 0% 16.4% 
No 89.7% 100% 78.5% 100% 83.6% 
Total 100% 100% 100% 100% 100% 
Chart 19: Any Codeine past year misuse… Any Codeine use in the past year (2016). P-value = 
.000 (alpha = .05). The following percent’s are for the overall adult female population: “Any 
Codeine use in the past year (2016)” for all females, 10.3% said “yes” and 89.7% said “no”. This 
table displays the quantitative data from the “Any Codeine use in the past year (2016)” variable 
in the NSDUH and has two categories or answer options. The “all females” column represents all 
the adult females (22,772) in the survey. NRNO is the urban and non-opioid group (control 
group), NRO is the urban opioid users, RNO is the rural non-opioid group, and RO is the rural 
opioid users. P0.05. 
 All females NRNO NRO RNO RO 
Yes 0.3% 0% 4.5% 0% 9.3% 
No 99.7% 100% 95.5% 100% 90.7% 
Total 100% 100% 100% 100% 100% 
Chart 20: Any Morphine products past year misuse… Any Morphine products use in the past 
year (2016). P-value = .000 (alpha = .05). The following percent’s are for the overall adult 
female population: “Any Morphine use in the past year (2016)” for all females, 0.3% said “yes” 
and 99.7% said “no”. This table displays the quantitative data from the “Any Morphine use in the 
past year (2016)” variable in the NSDUH and has two categories or answer options. The “all 
females” column represents all the adult females (22,772) in the survey. NRNO is the urban and 
Rural Health Disparities Impact Opioid Use Disorders and Women78 
 
non-opioid group (control group), NRO is the urban opioid users, RNO is the rural non-opioid 
group, and RO is the rural opioid users. P0.05. 
 All females NRNO NRO RNO RO 
Yes 0.1% 0% 2.1% 0% 4.2% 
No 99.9% 100% 97.9% 100% 95.8% 
Total 100% 100% 100% 100% 100% 
Chart 21: Any Fentanyl past year misuse… Any Fentanyl use in the past year (2016). P-value = 
.000 (alpha = .05). The following percent’s are for the overall adult female population: “Any 
Fentanyl use in the past year (2016)” for all females, 0.1% said “yes” and 99.9% said “no”. This 
table displays the quantitative data from the “Any Fentanyl use in the past year (2016)” variable 
in the NSDUH and has two categories or answer options. The “all females” column represents all 
the adult females (22,772) in the survey. NRNO is the urban and non-opioid group (control 
group), NRO is the urban opioid users, RNO is the rural non-opioid group, and RO is the rural 
opioid users. P0.05. 
 All females NRNO NRO RNO RO 
Yes 0.3% 0% 5% 0% 9.3% 
No 99.7% 100% 95% 100% 90.7% 
Total 100% 100% 100% 100% 100% 
Chart 22: Any Buprenorphine past year misuse… Any Buprenorphine use in the past year 
(2016). P-value = .000 (alpha = .05). The following percent’s are for the overall adult female 
population: “Any Buprenorphine use in the past year (2016)” for all females, 0.3% said “yes” 
and 99.7% said “no”. This table displays the quantitative data from the “Any Buprenorphine use 
in the past year (2016)” variable in the NSDUH and has two categories or answer options. The 
“all females” column represents all the adult females (22,772) in the survey. NRNO is the urban 
and non-opioid group (control group), NRO is the urban opioid users, RNO is the rural non-
opioid group, and RO is the rural opioid users. P0.05. 
 All females NRNO NRO RNO RO 
Yes 0.2% 0% 3% 0% 5.1% 
No 99.8% 100% 97% 100% 94.9% 
Total 100% 100% 100% 100% 100% 
Chart 23: Any Oxymorphone past year misuse… Any Oxymorphone use in the past year 
(2016). P-value = .000 (alpha = .05). The following percent’s are for the overall adult female 
population: “Any Oxymorphone use in the past year (2016)” for all females, 0.2% said “yes” and 
99.8% said “no”. This table displays the quantitative data from the “Any Oxymorphone use in 
the past year (2016)” variable in the NSDUH and has two categories or answer options. The “all 
females” column represents all the adult females (22,772) in the survey. NRNO is the urban and 
non-opioid group (control group), NRO is the urban opioid users, RNO is the rural non-opioid 
group, and RO is the rural opioid users. P0.05. 
 All females NRNO NRO RNO RO 
Yes 0.6% 0% 11.5% 0% 16.3% 
No 99.4% 100% 88.5% 100% 83.7% 
Total 100% 100% 100% 100% 100% 
Chart 24: Any OxyContin past year misuse… Any OxyContin use in the past year (2016). P-
value = .000 (alpha = .05). The following percent’s are for the overall adult female population: 
“Any OxyContin use in the past year (2016)” for all females, 0.6% said “yes” and 99.4% said 
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“no”. This table displays the quantitative data from the “Any OxyContin use in the past year 
(2016)” variable in the NSDUH and has two categories or answer options. The “all females” 
column represents all the adult females (22,772) in the survey. NRNO is the urban and non-
opioid group (control group), NRO is the urban opioid users, RNO is the rural non-opioid group, 
and RO is the rural opioid users. P0.05. 
 All females NRNO NRO RNO RO 
Yes 3% 0% 55% 0% 59.3% 
No 97% 100% 45% 100% 40.7% 
Total 100% 100% 100% 100% 100% 
Chart 25: Any Hydrocodone past year misuse… Any Hydrocodone use in the past year (2016). 
P-value = .000 (alpha = .05). The following percent’s are for the overall adult female population: 
“Any Hydrocodone use in the past year (2016)” for all females, 3% said “yes” and 97% said 
“no”. This table displays the quantitative data from the “Any Hydrocodone use in the past year 
(2016)” variable in the NSDUH and has two categories or answer options. The “all females” 
column represents all the adult females (22,772) in the survey. NRNO is the urban and non-
opioid group (control group), NRO is the urban opioid users, RNO is the rural non-opioid group, 
and RO is the rural opioid users. P0.05. 
 All females NRNO NRO RNO RO 
Yes 0.3% 0% 35% 0% 36.4% 
No 99.7% 100% 65% 100% 63.6% 
Total 100% 100% 100% 100% 100% 
Chart 26: Any Oxycodone products past year misuse… Any Oxycodone use in the past year 
(2016). P-value = .000 (alpha = .05). The following percent’s are for the overall adult female 
population: “Any Oxycodone use in the past year (2016)” for all females, 0.3% said “yes” and 
99.7% said “no”. This table displays the quantitative data from the “Any Oxycodone use in the 
past year (2016)” variable in the NSDUH and has two categories or answer options. The “all 
females” column represents all the adult females (22,772) in the survey. NRNO is the urban and 
non-opioid group (control group), NRO is the urban opioid users, RNO is the rural non-opioid 
group, and RO is the rural opioid users. P0.05. 
 All females NRNO NRO RNO RO 
Yes 1% 0% 17% 0% 20% 
No 99% 100% 83% 100% 80% 
Total 100% 100% 100% 100% 100% 
Chart 27: Any Tramadol past year misuse… Any Tramadol use in the past year (2016). P-value 
= .000 (alpha = .05). The following percent’s are for the overall adult female population: “Any 
Tramadol use in the past year (2016)” for all females, 1% said “yes” and 99% said “no”. This 
table displays the quantitative data from the “Any Tramadol use in the past year (2016)” variable 
in the NSDUH and has two categories or answer options. The “all females” column represents all 
the adult females (22,772) in the survey. NRNO is the urban and non-opioid group (control 
group), NRO is the urban opioid users, RNO is the rural non-opioid group, and RO is the rural 
opioid users. P0.05. 
 All females NRNO NRO RNO RO 
Straight % 92.4% 78% 94% 76.2% 
Gay % 2% 4% 1.2% 1.4% 
Bisexual % 5.6% 18% 4.8% 22.4% 
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Total 100% 100% 100% 100% 100% 
Chart 28: Sexual identity… The sexual identity (2016). P-value = .000 (alpha = .05). The 
following percent’s are for the overall adult female population: “The sexual identity for all 
females, 0.2% said “yes” and 99.8% said “no”. This table displays the quantitative data from the 
“Any Hydromorphone use in the past year (2016)” variable in the NSDUH and has three 
categories or answer options. The “all females” column represents all the adult females (22,772) 
in the survey. NRNO is the urban and non-opioid group (control group), NRO is the urban opioid 
users, RNO is the rural non-opioid group, and RO is the rural opioid users. P0.05.  
 All females NRNO NRO RNO RO 
Yes 37% 37% 46.3% 34.1% 42% 
No 63% 63% 53.7% 65.9% 58% 
Total 100% 100% 100% 100% 100% 
Chart 29: Ever told had asthma… Ever told you had asthma. P-value = .000 (alpha = .05). The 
following percent’s are for the overall adult female population: “Ever told you had asthma” for 
all females, 37% said “yes” and 63% said “no”. This table displays the quantitative data from the 
“Ever told you had asthma” variable in the NSDUH and has two categories or answer options. 
The “all females” column represents all the adult females (22,772) in the survey. NRNO is the 
urban and non-opioid group (control group), NRO is the urban opioid users, RNO is the rural 
non-opioid group, and RO is the rural opioid users. P0.05.  
 All females NRNO NRO RNO RO 
Yes 11% 10% 12.2% 13% 17% 
No 89% 90% 87.8% 87% 83% 
Total 100% 100% 100% 100% 100% 
Chart 30: Ever told had chronic bronchitis… Ever told you had chronic bronchitis. P-value = 
.000 (alpha = .05). The following percent’s are for the overall adult female population: “Ever 
told you had chronic bronchitis” for all females, 11% said “yes” and 89% said “no”. This table 
displays the quantitative data from the “Ever told you had chronic bronchitis” variable in the 
NSDUH and has two categories or answer options. The “all females” column represents all the 
adult females (22,772) in the survey. NRNO is the urban and non-opioid group (control group), 
NRO is the urban opioid users, RNO is the rural non-opioid group, and RO is the rural opioid 
users. P0.05. 
 All females NRNO NRO RNO RO 
Yes 4% 4% 4% 4% 0% 
No 96% 96% 96% 96% 100% 
Total 100% 100% 100% 100% 100% 
Chart 31: Ever told had kidney disease… Ever told you had kidney disease. P-value = .000 
(alpha = .05). The following percent’s are for the overall adult female population: “Ever told you 
had kidney disease” for all females, 4% said “yes” and 96% said “no”. This table displays the 
quantitative data from the “Ever told you had kidney disease” variable in the NSDUH and has 
two categories or answer options. The “all females” column represents all the adult females 
(22,772) in the survey. NRNO is the urban and non-opioid group (control group), NRO is the 
urban opioid users, RNO is the rural non-opioid group, and RO is the rural opioid users. P0.05.  
 All females NRNO NRO RNO RO 
Yes 2.4% 2% 10% 2% 8% 
No 97.6% 98% 90% 98% 92% 
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Total 100% 100% 100% 100% 100% 
Chart 32: Ever told had Hepatitis… Ever told you had Hepatitis. P-value = .000 (alpha = .05). 
The following percent’s are for the overall adult female population: “Ever told you had 
Hepatitis” for all females, 2.4% said “yes” and 97.6% said “no”. This table displays the 
quantitative data from the “Ever told you had Hepatitis” variable in the NSDUH and has two 
categories or answer options. The “all females” column represents all the adult females (22,772) 
in the survey. NRNO is the urban and non-opioid group (control group), NRO is the urban opioid 
users, RNO is the rural non-opioid group, and RO is the rural opioid users. P0.05. 
 All females NRNO NRO RNO RO 
Yes 0.5% 0.5% 1.2% 1% 1.3% 
No 99.5% 99.5% 98.8% 99% 98.7% 
Total 100% 100% 100% 100% 100% 
Chart 33: Ever told had cirrhosis of the liver… Ever told you had cirrhosis of liver. P-value = 
.000 (alpha = .05). The following percent’s are for the overall adult female population: “Ever 
told you had cirrhosis of the liver” for all females, 0.5% said “yes” and 99.5% said “no”. This 
table displays the quantitative data from the “Ever told you had cirrhosis of the liver”. variable in 
the NSDUH and has two categories or answer options. The “all females” column represents all 
the adult females (22,772) in the survey. NRNO is the urban and non-opioid group (control 
group), NRO is the urban opioid users, RNO is the rural non-opioid group, and RO is the rural 
opioid users. P0.05. 
 All females NRNO NRO RNO RO 
Yes 12.4% 13% 9% 12.5% 6.6% 
No 87.6% 87% 91% 87.5% 93.4% 
Total 100% 100% 100% 100% 100% 
Chart 34: Ever told had cancer… Ever told you had cancer. P-value = .000 (alpha = .05). The 
following percent’s are for the overall adult female population: “Ever told you had cancer” for 
all females, 12.4% said “yes” and 89% said “no”. This table displays the quantitative data from 
the “Ever told you had cancer” variable in the NSDUH and has two categories or answer options. 
The “all females” column represents all the adult females (22,772) in the survey. NRNO is the 
urban and non-opioid group (control group), NRO is the urban opioid users, RNO is the rural 
non-opioid group, and RO is the rural opioid users. P0.05. 
 All females NRNO NRO RNO RO 
SD 17% 16.4% 26% 16% 27.5% 
D 13.3% 13.4% 18% 12% 17.1% 
A 33.3% 33.4% 33.4% 33% 32.2% 
SA 36.4% 36.8% 22.6% 39% 23.3% 
Total 100% 100% 100% 100% 100% 
Chart 35: Are religious beliefs important… Are religious beliefs important? P-value = .000 
(alpha = .05). The following percent’s are for the overall adult female population: “Are religious 
beliefs important?” for all females, 17% said “strongly disagree” and 13.3% said “disagree”, 
33.3% said they agree, and 36.4% said they strongly agree. This table displays the quantitative 
data from the “Ever told you had chronic bronchitis” variable in the NSDUH and has four 
categories or answer options. The “all females” column represents all the adult females (22,772) 
in the survey. NRNO is the urban and non-opioid group (control group), NRO is the urban opioid 
users, RNO is the rural non-opioid group, and RO is the rural opioid users. P0.05. 
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 All females NRO RO 
1.Rel. pain 3% 60% 64% 
2. Get high 0.4% 21% 20% 
3. Experiment 0.1% 3% 1% 
4. Cope with stressors 0.5% 10% 11% 
5. Poly-drug use 0.2% 1% 1% 
6. Other 0.2% 2% 1% 
7. Did not misuse 0.1% 3% 2% 
Total 100% 100% 100% 
Chart 36: Reason for using pain reliever… The reason for using the pain reliever. P-value = 
.000 (alpha = .05). The following percent’s are for the overall adult female population: “Ever 
told you had chronic bronchitis” for all females, 3% said “to relieve pain” and 0.4% said to get 
high”, 0.1% said “to experiment”, 0.5% said “to cope with stressors”, 0.2% said “because of 
poly-drug use”, 0.2% said “for other reasons not listed in the survey”, and 0.1% said “they did 
not misuse”. This table displays the quantitative data from the “Reason for using pain reliever” 
variable in the NSDUH and has seven categories or answer options. The “all females” column 
represents all the adult females (22,772) in the survey. NRNO is the urban and non-opioid group 
(control group), NRO is the urban opioid users, RNO is the rural non-opioid group, and RO is 
the rural opioid users. P0.05. 
 All females NRNO NRO RNO RO 
Yes 3.5% 3.4% 6% 4% 5% 
No 96.5% 96.6% 94% 96% 95% 
Total 100% 100% 100% 100% 100% 
Chart 37: Family received welfare/job placement/childcare in past year… Has your family ever 
received welfare/job placement/childcare in the past year (2016)? P-value = .000 (alpha = .05). 
The following percent’s are for the overall adult female population: “Family received welfare/job 
placement/childcare in past year” for all females, 3.5% said “yes” and 96.5% said “no”. This 
table displays the quantitative data from the “Family received welfare/job placement/childcare in 
past year?” variable in the NSDUH and has two categories or answer options. The “all females” 
column represents all the adult females (22,772) in the survey. NRNO is the urban and non-
opioid group (control group), NRO is the urban opioid users, RNO is the rural non-opioid group, 
and RO is the rural opioid users. P0.05. 
 All females NRNO NRO RNO RO 
Yes 6% 5% 23% 4.4% 25.7% 
No 94% 95% 77% 95.6% 74.3% 
Total 100% 100% 100% 100% 100% 
Chart 38: Approached by someone selling drugs… Have you been approached by someone 
selling drugs in the past year (2016)? P-value = .000 (alpha = .05). The following percent’s are 
for the overall adult female population: “Have you been approached by someone selling drugs in 
the past year (2016)” for all females, 6% said “yes” and 94% said “no”. This table displays the 
quantitative data from the “Have you been approached by someone selling drugs in the past year 
(2016)?” variable in the NSDUH and has two categories or answer options. The “all females” 
column represents all the adult females (22,772) in the survey. NRNO is the urban and non-
opioid group (control group), NRO is the urban opioid users, RNO is the rural non-opioid group, 
and RO is the rural opioid users. P0.05. 
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 All females NRNO NRO RNO RO 
Yes 11.4% 11% 15% 12.3% 17.3% 
No 88.6% 89% 85% 87.7% 82.7% 
Total 100% 100% 100% 100% 100% 
Chart 39: Stayed overnight as an inpatient in the hospital in the past year… Have you stayed in 
a hospital overnight as an inpatient in the past year (2016)? P-value = .000 (alpha = .05). The 
following percent’s are for the overall adult female population: “Have you stayed in a hospital 
overnight as an inpatient in the past year (2016)” for all females, 11.4% said “yes” and 88.6% 
said “no”. This table displays the quantitative data from the “Have you stayed in a hospital 
overnight as an inpatient in the past year (2016)?” variable in the NSDUH and has two categories 
or answer options. The “all females” column represents all the adult females (22,772) in the 
survey. NRNO is the urban and non-opioid group (control group), NRO is the urban opioid 
users, RNO is the rural non-opioid group, and RO is the rural opioid users. P0.05. 
 All females NRNO NRO RNO RO 
Yes 11.2% 10% 26% 12.3% 34% 
No 88.8% 90% 74% 87.7% 66% 
Total 100% 100% 100% 100% 100% 
Chart 40: Ever arrested and booked for breaking the law…Ever been arrested and booked for 
breaking the law? P-value = .000 (alpha = .05). The following percent’s are for the overall adult 
female population: “Ever arrested and booked for breaking the law in the past year (2016)” for 
all females, 11.2% said “yes” and 88.8% said “no”. This table displays the quantitative data from 
the “Ever arrested and booked for breaking the law” in the past year (2016)?” variable in the 
NSDUH and has two categories or answer options. The “all females” column represents all the 
adult females (22,772) in the survey. NRNO is the urban and non-opioid group (control group), 
NRO is the urban opioid users, RNO is the rural non-opioid group, and RO is the rural opioid 
users. P0.05.  
 All females NRNO NRO RNO RO 
Yes 0.3% 0.3% 1.5% 0.2% 3% 
No 99.7% 99.7% 98.5% 99.8% 97% 
Total 100% 100% 100% 100% 100% 
Chart 41: Was on parole in the past year… Have you been on parole in the past year? P-value = 
.000 (alpha = .05). The following percent’s are for the overall adult female population: “Have 
you been on parole in the past year (2016)” for all females, 0.3% said “yes” and 99.7% said 
“no”. This table displays the quantitative data from the “Have you been on parole” in the past 
year (2016)?” variable in the NSDUH and has two categories or answer options. The “all 
females” column represents all the adult females (22,772) in the survey. NRNO is the urban and 
non-opioid group (control group), NRO is the urban opioid users, RNO is the rural non-opioid 
group, and RO is the rural opioid users. P0.05.  
 All females NRNO NRO RNO RO 
Yes 41% 36% 45% 39% 64% 
No 59% 64% 55% 61% 36% 
Total 100% 100% 100% 100% 100% 
Chart 42: Received treatment from a mental health center in the past year… Have you received 
treatment from mental health center in the past year? P-value = .000 (alpha = .05). The following 
percent’s are for the overall adult female population: “Have you received treatment from mental 
health center in the past year (2016)” for all females, 41% said “yes” and 59% said “no”. This 
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table displays the quantitative data from the “” in the past year (2016)?” variable in the NSDUH 
and has two categories or answer options. The “Have you received treatment from mental health 
center all females” column represents all the adult females (22,772) in the survey. NRNO is the 
urban and non-opioid group (control group), NRO is the urban opioid users, RNO is the rural 
non-opioid group, and RO is the rural opioid users. P0.05.  
 All females NRNO NRO RNO RO 
Yes 27% 23% 30% 20% 59% 
No 73% 77% 70% 80% 41% 
Total 100% 100% 100% 100% 100% 
Chart 43: Received treatment from a rehab center in the past year…Have you received 
treatment from a rehab center in the past year? P-value = .000 (alpha = .05). The following 
percent’s are for the overall adult female population: “Have you received treatment from a rehab 
center in the past year (2016)” for all females, 27% said “yes” and 73% said “no”. This table 
displays the quantitative data from the “Have you received treatment from a rehab center in the 
past year (2016)?” variable in the NSDUH and has two categories or answer options. “The 
Received treatment from a rehab center in the past year” column represents all the adult females 
(22,772) in the survey. NRNO is the urban and non-opioid group (control group), NRO is the 
urban opioid users, RNO is the rural non-opioid group, and RO is the rural opioid users. P0.05.  
 All females NRNO NRO RNO RO 
Yes 23% 18% 27% 23% 41% 
No 77% 82% 73% 77% 59% 
Total 100% 100% 100% 100% 100% 
Chart 44: Received treatment in a hospital in the past year… Have you received treatment in a 
hospital in in the past year? P-value = .000 (alpha = .05). The following percent’s are for the 
overall adult female population: “Have you received treatment in a hospital in the past year 
(2016)” for all females, 23% said “yes” and 77% said “no”. This table displays the quantitative 
data from the “Have you received treatment in a hospital in the past year (2016)?” variable in the 
NSDUH and has two categories or answer options. “The Received treatment in a hospital in the 
past year” column represents all the adult females (22,772) in the survey. NRNO is the urban and 
non-opioid group (control group), NRO is the urban opioid users, RNO is the rural non-opioid 
group, and RO is the rural opioid users. P0.05.  
 All females NRNO NRO RNO RO 
Yes 18% 16% 24% 14% 23% 
No 82% 84% 76% 86% 77% 
Total 100% 100% 100% 100% 100% 
Chart 45: Received treatment in an emergency room in the past year…Have you received 
treatment in an emergency room in the past year? P-value = .000 (alpha = .05). The following 
percent’s are for the overall adult female population: “Have you received treatment in an 
emergency room in the past year (2016)” for all females, 18% said “yes” and 82% said “no”. 
This table displays the quantitative data from the “Have you received treatment in an emergency 
room in the past year (2016)?” variable in the NSDUH and has two categories or answer options. 
“The Received treatment in an emergency room in the past year” column represents all the adult 
females (22,772) in the survey. NRNO is the urban and non-opioid group (control group), NRO 
is the urban opioid users, RNO is the rural non-opioid group, and RO is the rural opioid users. 
P0.05.  
 All females NRNO NRO RNO RO 
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Yes 1.4% 1.3% 1.6% 1.7% 3% 
No 98.6% 98.7% 98.4% 98.3% 97% 
Total 100% 100% 100% 100% 100% 
Chart 46: Ever been in the US armed forces… Ever been in the US armed forces? P-value = 
.000 (alpha = .05). The following percent’s are for the overall adult female population: “Have 
you ever been in the US armed forces? For all females, 1.4% said “yes” and 98.6% said “no”. 
This table displays the quantitative data from the “Have you ever been in the US armed forces?” 
variable in the NSDUH and has two categories or answer options. “The ever been in US armed 
forces” columns represent all the adult females (22,772) in the survey. NRNO is the urban and 
non-opioid group (control group), NRO is the urban opioid users, RNO is the rural non-opioid 
group, and RO is the rural opioid users. P0.05.  
 All females NRNO NRO RNO RO 
Yes 90.5% 91% 89.4% 90.4% 91.5% 
No 9.5% 9% 10.6% 9.6% 8.5% 
Total 100% 100% 100% 100% 100% 
Chart 47: Overall health insurance… Your overall health insurance P-value = .000 (alpha = 
.05). The following percent’s are for the overall adult female population: “The overall health 
insurance coverage in the past year (2016)” for all females, 90.5% said “yes” and 9.5% said 
“no”. This table displays the quantitative data from the “Overall health insurance coverage in the 
past year (2016)?” variable in the NSDUH and has two categories or answer options. “The 
overall health insurance coverage in the past year” column represents all the adult females 
(22,772) in the survey. NRNO is the urban and non-opioid group (control group), NRO is the 
urban opioid users, RNO is the rural non-opioid group, and RO is the rural opioid users. P0.05.  
 All females NRNO NRO RNO RO 
1 67.3% 68% 60.5% 67.4% 59% 
2 23.3% 23% 25% 24% 27% 
3 6.4% 6.3% 10% 6.1% 11% 
4+ 3% 2.7% 4.5% 2.5% 3% 
Total 100% 100% 100% 100% 100% 
Chart 48: Number of employees in the past year… The number of employees in the past year? 
P-value = .000 (alpha = .05). The following percent’s are for the overall adult female population: 
“The number of employers in the past year (2016)” for all females, 67.3% said “one” and 23.3% 
said “two”, 6.4% said “three”, 3% said they had “four or more jobs” in the past year. This table 
displays the quantitative data from the “The number of employees in the past year (2016)?” 
variable in the NSDUH and has four categories or answer options. “The number of employees in 
the past year” column represents all the adult females (22,772) in the survey. NRNO is the urban 
and non-opioid group (control group), NRO is the urban opioid users, RNO is the rural non-
opioid group, and RO is the rural opioid users. P0.05.  
 NRO RO 
1.Did not misuse 95% 90% 
2. Misused 5% 10% 
Total 100% 100% 
Chart 49: Ever smoked heroin… Have you ever smoked heroin? P-value = .000 (alpha = .05). 
The following percent’s are for the overall adult female population: “Have you ever smoked 
heroin” for all females, 5% said “yes” and 95% said “no”. This table displays the quantitative 
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data from the “Have you ever smoked heroin?” variable in the NSDUH and has two categories or 
answer options. “The ever smoked heroin” columns represent all the adult females (22,772) in 
the survey. NRNO is the urban and non-opioid group (control group), NRO is the urban opioid 
users, RNO is the rural non-opioid group, and RO is the rural opioid users. This table only 
displays the two test groups’ urban female opioid users and rural female opioid users. P0.05.  
 NRO RO 
1.No 98% 85% 
2. Yes 2% 15% 
Total 100% 100% 
Chart 50: Ever sniffed heroin… Ever sniffed heroin… Have you ever sniffed heroin? P-value = 
.000 (alpha = .05). The following percent’s are for the overall adult female population: “Have 
you ever smoked heroin” for all urban female opioid users, 2% said “yes” and 98% said “no”. 
Whereas the rural female users reported 85% “no” and 15% said “yes”. This table displays the 
quantitative data from the “Have you ever sniffed heroin?” variable in the NSDUH and has two 
categories or answer options. “The ever sniffed heroin” columns represent all the adult females 
(22,772) in the survey. NRNO is the urban and non-opioid group (control group), NRO is the 
urban opioid users, RNO is the rural non-opioid group, and RO is the rural opioid users. This 
table only displays the two test groups’ urban female opioid users and rural female opioid users. 
P0.05.  
 NRNO NRO RNO RO 
No 97% 83% 97% 87% 
Yes 3% 17% 3% 13% 
Total 100% 100% 100% 100% 
Chart 51: Used marijuana with last alcohol drink… Used marijuana with last alcohol drink in 
the past year? P-value = .000 (alpha = .05). The following percent’s are for the overall adult 
female population: “Used marijuana with last alcohol drink in the past year (2016)” for all urban 
female users, 3% said “yes” and 97% said “no “For rural female users 87% said “no” and 13% 
said “yes”. This table displays the quantitative data from the “Used marijuana with last alcohol 
drink in the past year (2016)?” variable in the NSDUH and has two categories or answer options. 
“Used marijuana with last alcohol drink in the past year” column represents all the adult females 
(22,772) in the survey. NRNO is the urban and non-opioid group (control group), NRO is the 
urban opioid users, RNO is the rural non-opioid group, and RO is the rural opioid users. P0.05.  
 NRNO NRO RNO RO 
Not easy 81% 70% 80% 64% 
Easy 19% 30% 20% 36% 
Total 100% 100% 100% 100% 
Chart 52: Difficult to obtain heroin… How difficult is it to obtain heroin? P-value = .000 (alpha 
= .05). The following percent’s are for the overall adult female population: “How difficult is it to 
obtain heroin” for all urban female users, 19% said “easy” and 81% said “not easy”. For rural 
female users 64% said “not easy” and 36% said “easy”. This table displays the quantitative data 
from the “How difficult is it to obtain heroin?” variable in the NSDUH and has two categories or 
answer options. “How difficult is it to obtain heroin” column represents all the adult females 
(22,772) in the survey. NRNO is the urban and non-opioid group (control group), NRO is the 
urban opioid users, RNO is the rural non-opioid group, and RO is the rural opioid users. P0.05.  
 NRNO NRO RNO RO 
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No 95% 92% 96% 100% 
Yes 5% 8% 4% 0% 
Total 100% 100% 100% 100% 
Chart 53: Received treatment in prison or jail… Received treatment in prison or jail in the past 
year? P-value = .000 (alpha = .05). The following percent’s are for the overall adult female 
population: “Received treatment in prison or jail in the past year (2016)” for all urban female 
users, 5% said “yes” and 95% said “no “For rural female users 0% said “yes” and 100% said 
“no”. This table displays the quantitative data from the “Received treatment in prison or jail in 
the past year (2016)?” variable in the NSDUH and has two categories or answer options. 
“Received treatment in prison or jail in the past year” column represents all the adult females 
(22,772) in the survey. NRNO is the urban and non-opioid group (control group), NRO is the 
urban opioid users, RNO is the rural non-opioid group, and RO is the rural opioid users. P0.05. 
 NRNO NRO RNO RO 
No 73% 69% 72% 59% 
Yes 27% 31% 28% 41% 
Total 100% 100% 100% 100% 
Chart 54: Received treatment in private doctor’s office… Received treatment in private doctor’s 
office in the past year? P-value = .000 (alpha = .05). The following percent’s are for the overall 
adult female population: “Received treatment in private doctor’s office in the past year (2016)” 
for all urban female users, 27% said “yes” and 73% said “no “For rural female users 41% said 
“yes” and 59% said “no”. This table displays the quantitative data from the “Received treatment 
in private doctor’s office in the past year (2016)?” variable in the NSDUH and has two 
categories or answer options. “Received treatment in private doctor’s office in the past year” 
column represents all the adult females (22,772) in the survey. NRNO is the urban and non-
opioid group (control group), NRO is the urban opioid users, RNO is the rural non-opioid group, 
and RO is the rural opioid users. P0.05. 
 NRNO NRO RNO RO 
No 82% 84% 80% 80% 
Yes 18% 16% 20% 20% 
Total 100% 100% 100% 100% 
Chart 55: Ever told you had heart condition… Ever told you had heart condition? P-value = 
.000 (alpha = .05). The following percent’s are for the overall adult female population: “Ever 
told you had heart condition” for all urban female users, 18% said “yes” and 82% said “no “For 
rural female users 20% said “yes” and 80% said “no”. This table displays the quantitative data 
from the “Ever told you had heart condition” variable in the NSDUH and has two categories or 
answer options. “Ever told you had heart condition” column represents all the adult females 
(22,772) in the survey. NRNO is the urban and non-opioid group (control group), NRO is the 
urban opioid users, RNO is the rural non-opioid group, and RO is the rural opioid users. P0.05. 
 NRNO NRO RNO RO 
No 79% 85% 77% 76% 
Yes 21% 15% 23% 24% 
Total 100% 100% 100% 100% 
Chart 56: Ever told you had sugar diabetes… Ever told you had sugar diabetes? P-value = .000 
(alpha = .05). The following percent’s are for the overall adult female population: “Ever told you 
had sugar diabetes” for all urban female users, 21% said “yes” and 79% said “no “For rural 
female users 24% said “yes” and 76% said “no”. This table displays the quantitative data from 
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the “Ever told you had sugar diabetes” variable in the NSDUH and has two categories or answer 
options. “Ever told you had sugar diabetes” column represents all the adult females (22,772) in 
the survey. NRNO is the urban and non-opioid group (control group), NRO is the urban opioid 
users, RNO is the rural non-opioid group, and RO is the rural opioid users. P0.05.  
 NRNO NRO RNO RO 
No 34% 12% 29% 0% 
Yes 66% 88% 71% 100% 
Total 100% 100% 100% 100% 
Chart 57: Emotional problems kept you from leaving the house… Emotional problems kept you 
from leaving the house? P-value = .000 (alpha = .05). The following percent’s are for the overall 
adult female population: “Emotional problems kept you from leaving the house” for all urban 
female users, 66% said “yes” and 34% said “no “For rural female users 100% said “yes” and 0% 
said “no”. This table displays the quantitative data from the “Emotional problems kept you from 
leaving the house” variable in the NSDUH and has two categories or answer options. “Emotional 
problems kept you from leaving the house” column represents all the adult females (22,772) in 
the survey. NRNO is the urban and non-opioid group (control group), NRO is the urban opioid 
users, RNO is the rural non-opioid group, and RO is the rural opioid users. P0.05.  
 NRNO NRO RNO RO 
No 79% 71% 77% 58% 
Yes 21% 29% 23% 42% 
Total 100% 100% 100% 100% 
Chart 58: Medicaid coverage…Do you have Medicaid health insurance coverage? P-value = 
.000 (alpha = .05). The following percent’s are for the overall adult female population: “Do you 
have Medicaid health insurance coverage” for all urban female users, 21% said “yes” and 79% 
said “no “For rural female users 42% said “yes” and 58% said “no”. This table displays the 
quantitative data from the “Do you have Medicaid health insurance coverage” variable in the 
NSDUH and has two categories or answer options. “Do you have Medicaid health insurance 
coverage” column represents all the adult females (22,772) in the survey. NRNO is the urban and 
non-opioid group (control group), NRO is the urban opioid users, RNO is the rural non-opioid 
group, and RO is the rural opioid users. P0.05.  
 NRNO NRO RNO RO 
No 36% 43% 39% 57% 
Yes 64% 57% 61% 43% 
Total 100% 100% 100% 100% 
Chart 59: Private health insurance …. Do you have Private health insurance coverage? P-value 
= .000 (alpha = .05). The following percent’s are for the overall adult female population: “Do 
you have Private health insurance coverage” for all urban female users, 64% said “yes” and 36% 
said “no “For rural female users 43% said “yes” and 57% said “no”. This table displays the 
quantitative data from the “Do you have Private health insurance coverage” variable in the 
NSDUH and has two categories or answer options. “Do you have Private health insurance 
coverage” column represents all the adult females (22,772) in the survey. NRNO is the urban and 
non-opioid group (control group), NRO is the urban opioid users, RNO is the rural non-opioid 
group, and RO is the rural opioid users. P0.05.  
 NRNO NRO RNO RO 
18-25 31% 41% 29% 45% 
26-34 20% 27% 19% 22% 
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35-49 28% 22% 26% 25% 
50-64 12% 8% 14% 5% 
65+ 9% 2% 12% 3% 
Total 100% 100% 100% 100% 
Chart 60: Age of adult female respondents… Age of adult female respondents? P-value = .000 
(alpha = .05). The following percent’s are for the overall adult female population: “Age of adult 
female respondents” for all urban female users, 31% said “18-25 years old”, 20% said “26-34 
years old”, 28% said “35-49 years old”, 12% said “50-64 years old” and 9% said “65 years or 
older”. For rural female users 45% said “18-25 years old”, 22% said “26-34 years old”, 25% said 
“35-49 years old”, 5% said “50-64 years old”, and 3% said “65 years or older”. This table 
displays the quantitative data from the “Age of adult female respondents” variable in the 
NSDUH and has five categories or answer options. “Age of adult female respondents” column 
represents all the adult females (22,772) in the survey. NRNO is the urban and non-opioid group 
(control group), NRO is the urban opioid users, RNO is the rural non-opioid group, and RO is 
the rural opioid users. P0.05.  
 NRNO NRO RNO RO 
No 99% 98% 100% 98% 
Yes 1% 2% 0% 2% 
Total 100% 100% 100% 100% 
Chart 61: Cocaine with last alcohol drink… Did you have Cocaine with your last alcohol drink? 
P-value = .000 (alpha = .05). The following percent’s are for the overall adult female population: 
“Did you have Cocaine with your last alcohol drink” for all urban female users, 1% said “yes” 
and 99% said “no “For rural female users 2% said “yes” and 98% said “no”. This table displays 
the quantitative data from the “Did you have Cocaine with your last alcohol drink” variable in 
the NSDUH and has two categories or answer options. “Did you have Cocaine with your last 
alcohol drink” column represents all the adult females (22,772) in the survey. NRNO is the urban 
and non-opioid group (control group), NRO is the urban opioid users, RNO is the rural non-
opioid group, and RO is the rural opioid users. P0.05.  
 NRO RO 
No 98% 99% 
Yes 2% 1% 
Total 100% 100% 
Chart 62: Heroin with last alcohol drink… Heroin with last alcohol drink? P-value = .000 (alpha 
= .05). The following percent’s are for the overall adult female population: “Heroin with last 
alcohol drink” for all urban female users, 2% said “yes” and 98% said “no “For rural female 
users 1% said “yes” and 99% said “no”. This table displays the quantitative data from the 
“Heroin with last alcohol drink” variable in the NSDUH and has two categories or answer 
options. “Heroin with last alcohol drink” column represents all the adult females (22,772) in the 
survey. NRNO is the urban and non-opioid group (control group), NRO is the urban opioid 
users, RNO is the rural non-opioid group, and RO is the rural opioid users. P0.05.  
 NRNO NRO RNO RO 
Not easy 80% 73% 78% 69% 
Easy 20% 27% 22% 31% 
Total 100% 100% 100% 100% 
Chart 63: How difficult is it to obtain crack… How difficult is it to obtain crack? P-value = .000 
(alpha = .05). The following percent’s are for the overall adult female population: “How difficult 
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is it to obtain crack” for all urban female users, 20% said “it’s easy” and 80% said “not easy”. 
For rural female users 31% said “easy” and 69% said “not easy”. This table displays the 
quantitative data from the “How difficult is it to obtain crack” variable in the NSDUH and has 
two categories or answer options. “How difficult is it to obtain crack” column represents all the 
adult females (22,772) in the survey. NRNO is the urban and non-opioid group (control group), 
NRO is the urban opioid users, RNO is the rural non-opioid group, and RO is the rural opioid 
users. P0.05.  
 NRNO NRO RNO RO 
No 98% 94% 98% 91% 
Yes 2% 6% 2% 9% 
Total 100% 100% 100% 100% 
Chart 64: Probation…Are you on probation during this year (2016)? P-value = .000 (alpha = 
.05). The following percent’s are for the overall adult female population: “Are you on probation 
during this year (2016)” for all urban female users, 2% said “yes” and 98% said “no “For rural 
female users 9% said “yes” and 91% said “no”. This table displays the quantitative data from the 
“Are you on probation during this year (2016)” variable in the NSDUH and has two categories or 
answer options. “Are you on probation during this year (2016)” column represents all the adult 
females (22,772) in the survey. NRNO is the urban and non-opioid group (control group), NRO 
is the urban opioid users, RNO is the rural non-opioid group, and RO is the rural opioid users. 
P0.05.  
 NRNO NRO RNO RO 
No 62% 69% 58% 68% 
Yes 38% 31% 42% 32% 
Total 100% 100% 100% 100% 
Chart 65: Ever told you had high blood pressure… Ever told you had high blood pressure? P-
value = .000 (alpha = .05). The following percent’s are for the overall adult female population: 
“Ever told you had high blood pressure” for all urban female users, 38% said “yes” and 62% said 
“no “For rural female users 32% said “yes” and 68% said “no”. This table displays the 
quantitative data from the “Ever told you had high blood pressure” variable in the NSDUH and 
has two categories or answer options. “Ever told you had high blood pressure” column represents 
all the adult females (22,772) in the survey. NRNO is the urban and non-opioid group (control 
group), NRO is the urban opioid users, RNO is the rural non-opioid group, and RO is the rural 
opioid users. P0.05.  
 NRNO NRO RNO RO 
No 86% 79% 86% 74% 
Yes 14% 21% 14% 26% 
Total 100% 100% 100% 100% 
Chart 66: Ever tried to kill yourself in the past year… Ever tried to kill yourself in the past year 
(2016)? P-value = .000 (alpha = .05). The following percent’s are for the overall adult female 
population: “Ever tried to kill yourself in the past year (2016)” for all urban female users, 14% 
said “yes” and 86% said “no “For rural female users 26% said “yes” and 74% said “no”. This 
table displays the quantitative data from the “Ever tried to kill yourself in the past year (2016)” 
variable in the NSDUH and has two categories or answer options. “Ever tried to kill yourself in 
the past year (2016)” column represents all the adult females (22,772) in the survey. NRNO is 
the urban and non-opioid group (control group), NRO is the urban opioid users, RNO is the rural 
non-opioid group, and RO is the rural opioid users. P0.05.  
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 NRNO NRO RNO RO 
No 97% 97% 96% 96% 
Yes 3% 3% 4% 4% 
Total 100% 100% 100% 100% 
Chart 67: Serious difficulty hearing… Serious difficulty hearing? P-value = .000 (alpha = .05). 
The following percent’s are for the overall adult female population: “Serious difficulty hearing” 
for all urban female users, 3% said “yes” and 97% said “no “For rural female users 4% said 
“yes” and 96% said “no”. This table displays the quantitative data from the “Serious difficulty 
hearing” variable in the NSDUH and has two categories or answer options. “Serious difficulty 
hearing” column represents all the adult females (22,772) in the survey. NRNO is the urban and 
non-opioid group (control group), NRO is the urban opioid users, RNO is the rural non-opioid 
group, and RO is the rural opioid users. P0.05.  
 NRNO NRO RNO RO 
No 96% 93% 95% 93% 
Yes 4% 7% 5% 7% 
Total 100% 100% 100% 100% 
Chart 68: Serious difficulty seeing… Serious difficulty seeing? P-value = .000 (alpha = .05). 
The following percent’s are for the overall adult female population: “Serious difficulty seeing” 
for all urban female users, 4% said “yes” and 96% said “no “For rural female users 7% said 
“yes” and 93% said “no”. This table displays the quantitative data from the “Serious difficulty 
seeing” variable in the NSDUH and has two categories or answer options. “Serious difficulty 
seeing” column represents all the adult females (22,772) in the survey. NRNO is the urban and 
non-opioid group (control group), NRO is the urban opioid users, RNO is the rural non-opioid 
group, and RO is the rural opioid users. P0.05.  
 NRNO NRO RNO RO 
No 92% 77% 90% 76% 
Yes 8% 23% 10% 24% 
Total 100% 100% 100% 100% 
Chart 69: Serious difficulty remembering or concentrating… Serious difficulty remembering or 
concentrating? P-value = .000 (alpha = .05). The following percent’s are for the overall adult 
female population: Serious difficulty remembering or concentrating “” for all urban female users, 
8% said “yes” and 92% said “no “For rural female users 24% said “yes” and 76% said “no”. This 
table displays the quantitative data from the “Serious difficulty remembering or concentrating” 
variable in the NSDUH and has two categories or answer options. “Serious difficulty 
remembering or concentrating” column represents all the adult females (22,772) in the survey. 
NRNO is the urban and non-opioid group (control group), NRO is the urban opioid users, RNO 
is the rural non-opioid group, and RO is the rural opioid users. P0.05.  
 NRNO NRO RNO RO 
No 92% 77% 90% 76% 
Yes 8% 23% 10% 24% 
Total 100% 100% 100% 100% 
Chart 70: Serious difficulty walking or climbing… Serious difficulty walking or climbing? P-
value = .000 (alpha = .05). The following percent’s are for the overall adult female population: 
“Serious difficulty walking or climbing” for all urban female users, 8% said “yes” and 92% said 
“no “For rural female users 24% said “yes” and 76% said “no”. This table displays the 
quantitative data from the “Serious difficulty walking or climbing” variable in the NSDUH and 
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has two categories or answer options. “Serious difficulty walking or climbing” column 
represents all the adult females (22,772) in the survey. NRNO is the urban and non-opioid group 
(control group), NRO is the urban opioid users, RNO is the rural non-opioid group, and RO is 
the rural opioid users. P0.05.  
 NRNO NRO RNO RO 
No 98% 97% 98% 96% 
Yes 2% 3% 2% 4% 
Total 100% 100% 100% 100% 
Chart 71: Serious difficulty dressing or bathing… Serious difficulty dressing or bathing? P-
value = .000 (alpha = .05). The following percent’s are for the overall adult female population: 
“Serious difficulty dressing or bathing” for all urban female users, 2% said “yes” and 98% said 
“no “For rural female users 4% said “yes” and 96% said “no”. This table displays the 
quantitative data from the “Serious difficulty dressing or bathing” variable in the NSDUH and 
has two categories or answer options. “Serious difficulty dressing or bathing” column represents 
all the adult females (22,772) in the survey. NRNO is the urban and non-opioid group (control 
group), NRO is the urban opioid users, RNO is the rural non-opioid group, and RO is the rural 
opioid users. P0.05.  
 NRNO NRO RNO RO 
No 95% 88% 93% 87% 
Yes 5% 12% 7% 13% 
Total 100% 100% 100% 100% 
Chart 72: Serious difficulty doing errands alone...Serious difficulty doing errands alone? P-
value = .000 (alpha = .05). The following percent’s are for the overall adult female population: “: 
Serious difficulty doing errands alone” for all urban female users, 5% said “yes” and 95% said 
“no “For rural female users 13% said “yes” and 87% said “no”. This table displays the 
quantitative data from the “Serious difficulty doing errands alone” variable in the NSDUH and 
has two categories or answer options. “Serious difficulty doing errands alone” column represents 
all the adult females (22,772) in the survey. NRNO is the urban and non-opioid group (control 
group), NRO is the urban opioid users, RNO is the rural non-opioid group, and RO is the rural 
opioid users. P0.05.  
 NRNO NRO RNO RO 
One 11% 9% 11% 9% 
Two 27% 30% 30% 29% 
Three 21% 21% 22% 21% 
Four 21% 19% 19% 19% 
Five 11% 12% 10% 12% 
Six+ 9% 9% 8% 10% 
Total 100% 100% 100% 100% 
Chart 73: Number of persons in HH… Number of persons in the household? P-value = .000 
(alpha = .05). The following percent’s are for the overall adult female population: “Number of 
persons in the household” for all urban female users, 11% said “one”, 27% said “two”, 21% said 
“three”, 21% said “four”, 11% said “five”, and 9% said “six or more”. For rural female users 9% 
said “one”, 29% said “two”, 21% said “three”, 19% said “four”, 12% said “five”, and 10% said 
“six or more”. This table displays the quantitative data from the “Number of persons in the 
household” variable in the NSDUH and has six categories or answer options. “Number of 
persons in the household” column represents all the adult females (22,772) in the survey. NRNO 
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is the urban and non-opioid group (control group), NRO is the urban opioid users, RNO is the 
rural non-opioid group, and RO is the rural opioid users. P0.05.  
 NRNO NRO RNO RO 
Zero 52% 55% 54% 51% 
One 21% 18% 19% 20% 
Two 17% 16% 15% 15% 
Three+ 11% 11% 12% 14% 
Total 100% 100% 100% 100% 
Chart 74: Number of children in HH under 18 years old… “Number of children in the 
household” for all urban female users, 52% said “zero”, 21% said “one”, 17% said “two”, 11% 
said “three or more”. For rural female users 51% said “zero”, 20% said “one”, 15% said “two”, 
14% said “three or more”. This table displays the quantitative data from the “Number of children 
in the household” variable in the NSDUH and has four categories or answer options. “Number of 
persons in the household” column represents all the adult females (22,772) in the survey. NRNO 
is the urban and non-opioid group (control group), NRO is the urban opioid users, RNO is the 
rural non-opioid group, and RO is the rural opioid users. P0.05.  
 NRNO NRO RNO RO 
Zero 84% 92% 83% 89% 
One 10% 7% 11% 7% 
Two+ 6% 1% 6% 4% 
Total 100% 100% 100% 100% 
Chart 75: Number of persons in HH over 65 years old… Number of persons in HH over 65 
years old? P-value = .000 (alpha = .05). The following percent’s are for the overall adult female 
population: “Number of persons in HH over 65 years old” for all urban female users, 84% said 
“zero”, 10% said “one”, and 6% said “two or more”. For rural female users 89% said “zero”, 7% 
said “one”, and 4% said “two or more”. This table displays the quantitative data from the 
“Number of persons in HH over 65 years old” variable in the NSDUH and has three categories 
or answer options. “Number of persons in HH over 65 years old” column represents all the adult 
females (22,772) in the survey. NRNO is the urban and non-opioid group (control group), NRO 
is the urban opioid users, RNO is the rural non-opioid group, and RO is the rural opioid users. 
P0.05.  
 NRNO NRO RNO RO 
No 93% 91% 94% 91% 
Yes 7% 9% 6% 9% 
Total 100% 100% 100% 100% 
Chart 76: Was the interview too long… Was the interview too long? P-value = .000 (alpha = 
.05). The following percent’s are for the overall adult female population: “Was the interview too 
long” for all urban female users, 7% said “yes” and 93% said “no “For rural female users 9% 
said “yes” and 91% said “no”. This table displays the quantitative data from the “Was the 
interview too long” variable in the NSDUH and has two categories or answer options. “Was the 
interview too long” column represents all the adult females (22,772) in the survey. NRNO is the 
urban and non-opioid group (control group), NRO is the urban opioid users, RNO is the rural 
non-opioid group, and RO is the rural opioid users. P0.05.  
 NRNO NRO RNO RO 
No 95% 96% 95% 99% 
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Yes 5% 4% 5% 1% 
Total 100% 100% 100% 100% 
Chart 77: Was the interview hard to understand…Was the interview hard to understand? P-
value = .000 (alpha = .05). The following percent’s are for the overall adult female population: 
“Was the interview hard to understand” for all urban female users, 5% said “yes” and 95% said 
“no “For rural female users 1% said “yes” and 99% said “no”. This table displays the 
quantitative data from the “Was the interview hard to understand” variable in the NSDUH and 
has two categories or answer options. “Was the interview hard to understand” column represents 
all the adult females (22,772) in the survey. NRNO is the urban and non-opioid group (control 
group), NRO is the urban opioid users, RNO is the rural non-opioid group, and RO is the rural 
opioid users. P0.05.  
 NRNO NRO RNO RO 
Never 59% 29% 59% 30% 
Sometimes 39% 64% 40% 67% 
Always 2% 7% 1% 3% 
Total 100% 100% 100% 100% 
Chart 78: Do you enjoy engaging in risky behaviors… Do you enjoy engaging in risky 
behaviors? P-value = .000 (alpha = .05). The following percent’s are for the overall adult female 
population: “Do you enjoy engaging in risky behaviors” for all urban female users, 59% said 
“never”, 39% said “sometimes”, and 2% said “always”. For rural female users 30% said “never”, 
67% said “sometimes”, and 3% said “always”. This table displays the quantitative data from the 
“Do you enjoy engaging in risky behaviors” variable in the NSDUH and has three categories or 
answer options. “Do you enjoy engaging in risky behaviors” column represents all the adult 
females (22,772) in the survey. NRNO is the urban and non-opioid group (control group), NRO 
is the urban opioid users, RNO is the rural non-opioid group, and RO is the rural opioid users. 
P0.05.  
 NRNO NRO RNO RO 
No 89% 95% 85% 93% 
Yes 11% 5% 15% 7% 
Total 100% 100% 100% 100% 
Chart 79: Are you covered by Medicare… Are you covered by Medicare? P-value = .000 (alpha 
= .05). The following percent’s are for the overall adult female population: “Are you covered by 
Medicare” for all urban female users, 11% said “yes” and 89% said “no “For rural female users 
7% said “yes” and 93% said “no”. This table displays the quantitative data from the “Are you 
covered by Medicare” variable in the NSDUH and has two categories or answer options. “Are 
you covered by Medicare” column represents all the adult females (22,772) in the survey. NRNO 
is the urban and non-opioid group (control group), NRO is the urban opioid users, RNO is the 
rural non-opioid group, and RO is the rural opioid users. P0.05.  
 NRNO NRO RNO RO 
No 20% 24% 18% 21% 
Yes 80% 76% 82% 79% 
Total 100% 100% 100% 100% 
Chart 80: Does your job have a written drug policy… Does your job have a written drug policy? 
P-value = .000 (alpha = .05). The following percent’s are for the overall adult female population: 
“Does your job have a written drug policy” for all urban female users, 80% said “yes” and 20% 
said “no “For rural female users 79% said “yes” and 21% said “no”. This table displays the 
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quantitative data from the “Does your job have a written drug policy” variable in the NSDUH 
and has two categories or answer options. “Does your job have a written drug policy” column 
represents all the adult females (22,772) in the survey. NRNO is the urban and non-opioid group 
(control group), NRO is the urban opioid users, RNO is the rural non-opioid group, and RO is 
the rural opioid users. P0.05.  
 NRNO NRO RNO RO 
No 93% 91% 91% 90% 
Yes 7% 9% 9% 10% 
Total 100% 100% 100% 100% 
Chart 81: Family or respondent receives SSI… Family or respondent receives SSI? P-value = 
.000 (alpha = .05). The following percent’s are for the overall adult female population: “Family 
or respondent receives SSI” for all urban female users, 7% said “yes” and 93% said “no “For 
rural female users 10% said “yes” and 90% said “no”. This table displays the quantitative data 
from the “Family or respondent receives SSI” variable in the NSDUH and has two categories or 
answer options. “Family or respondent receives SSI” column represents all the adult females 
(22,772) in the survey. NRNO is the urban and non-opioid group (control group), NRO is the 
urban opioid users, RNO is the rural non-opioid group, and RO is the rural opioid users. P0.05.  
 NRNO NRO RNO RO 
No 80% 70% 78% 59% 
Yes 20% 30% 22% 41% 
Total 100% 100% 100% 100% 
Chart 82: Family or respondent receives food stamps… Family or respondent receives food 
stamps? P-value = .000 (alpha = .05). The following percent’s are for the overall adult female 
population: “Family or respondent receives food stamps” for all urban female users, 20% said 
“yes” and 80% said “no “For rural female users 41% said “yes” and 59% said “no”. This table 
displays the quantitative data from the “Family or respondent receives food stamps” variable in 
the NSDUH and has two categories or answer options. “Family or respondent receives food 
stamps” column represents all the adult females (22,772) in the survey. NRNO is the urban and 
non-opioid group (control group), NRO is the urban opioid users, RNO is the rural non-opioid 
group, and RO is the rural opioid users. P0.05.  
 NRNO NRO RNO RO 
SD 30% 43% 29% 39% 
D 40% 37% 38% 43% 
A 20% 14% 23% 14% 
SA 10% 6% 10% 4% 
Total 100% 100% 100% 100% 
Chart 83: Friends share religious beliefs is important… Friends share religious beliefs is 
important? P-value = .000 (alpha = .05). The following percent’s are for the overall adult female 
population: “Friends share religious beliefs is important” for all urban female users, 30% said 
“strongly disagree” and 40% said “disagree”, 20% said “agree”, and 10% said “strongly agree”. 
For rural female users 39% said “strongly disagree”, 43% said “disagree”, 14% said “agree”, and 
4% said “strongly agree”. This table displays the quantitative data from the “Friends share 
religious beliefs is important” variable in the NSDUH and has four categories or answer options. 
“Friends share religious beliefs is important” column represents all the adult females (22,772) in 
the survey. NRNO is the urban and non-opioid group (control group), NRO is the urban opioid 
users, RNO is the rural non-opioid group, and RO is the rural opioid users. P0.05.  
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 NRNO NRO RNO RO 
SD 16% 27% 16% 29% 
D 17% 22% 14% 18% 
A 35% 33% 36% 36% 
SA 32% 18% 34% 17% 
Total 100% 100% 100% 100% 
Chart 84: Religion influences your decisions…Religion influences your decision?  P-value = 
.000 (alpha = .05). The following percent’s are for the overall adult female population: “Religion 
influences your decision” for all urban female users, 16% said “strongly disagree” and 17% said 
“disagree”, 35% said “agree”, and 32% said “strongly agree”. For rural female users 29% said 
“strongly disagree”, 18% said “disagree”, 36% said “agree”, and 17% said “strongly agree”. This 
table displays the quantitative data from the “Religion influences your decision” variable in the 
NSDUH and has four categories or answer options. “Religion influences your decision” column 
represents all the adult females (22,772) in the survey. NRNO is the urban and non-opioid group 
(control group), NRO is the urban opioid users, RNO is the rural non-opioid group, and RO is 
the rural opioid users. P0.05.  
 NRNO NRO RNO RO 
Married 41% 27% 45% 27% 
Widowed 4% 2% 5% 1% 
Divorced 13% 14% 14% 20% 
Never 
married/single 
42% 57% 36% 52% 
Total 100% 100% 100% 100% 
Chart 85: Marital status… Marital status? P-value = .000 (alpha = .05). The following percent’s 
are for the overall adult female population: “Marital status” for all urban female users, 41% said 
“married” and 4% said widowed”, 13% said “divorced”, and 42% said “single”. For rural female 
users 27% said “married” and 1% said “widowed”, 20% said “divorced”, and 52% said “single”. 
This table displays the quantitative data from the “Marital status” variable in the NSDUH and 
has four categories or answer options. “Marital status” column represents all the adult females 
(22,772) in the survey. NRNO is the urban and non-opioid group (control group), NRO is the 
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